Domo (DOMO) 10-Q 8 Jun 20 2021 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Apr. 30, 2020	May 31, 2020
Class of Stock [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Apr. 30, 2020
Document Transition Report	false
Entity File Number	001-38553
Entity Registrant Name	DOMO, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	27-3687433
Entity Address, Address Line One	772 East Utah Valley Drive
Entity Address, City or Town	American Fork
Entity Address, State or Province	UT
Entity Address, Postal Zip Code	84003
City Area Code	801
Local Phone Number	899-1000
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Title of 12(b) Security	Class B Common Stock, par value $0.001 per share
Trading Symbol	DOMO
Security Exchange Name	NASDAQ
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Central Index Key	0001505952
Current Fiscal Year End Date	--01-31
Class A Common Stock
Class of Stock [Line Items]
Entity Common Stock, Shares Outstanding		3,263,659
Class B Common Stock
Class of Stock [Line Items]
Entity Common Stock, Shares Outstanding		25,551,402

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Thousands	Apr. 30, 2020	Jan. 31, 2020
Current assets:
Cash and cash equivalents	$ 75,543	$ 80,843
Short-term investments	12,571	17,967
Accounts receivable, net of allowances of $2,164 and $4,023 as of January 31, 2020 and April 30, 2020, respectively	29,644	47,967
Contract acquisition costs, net	12,513	12,676
Prepaid expenses and other current assets	12,507	12,809
Total current assets	142,778	172,262
Property and equipment, net	13,111	12,816
Right-of-use assets	11,095
Contract acquisition costs, noncurrent, net	15,641	17,083
Intangible assets, net	3,815	3,865
Goodwill	9,478	9,478
Other assets	1,300	1,234
Total assets	197,218	216,738
Current liabilities:
Accounts payable	2,347	2,298
Accrued expenses and other current liabilities	30,892	46,473
Lease liabilities	3,610
Deferred revenue	104,804	105,290
Total current liabilities	141,653	154,061
Lease liabilities, noncurrent	8,166
Deferred revenue, noncurrent	2,916	4,454
Other liabilities, noncurrent	6,415	6,329
Long-term debt	102,056	101,074
Total liabilities	261,206	265,918
Commitments and contingencies
Stockholders' deficit:
Preferred stock, $0.001 par value per share; 10,000 shares authorized as of January 31, 2020 and April 30, 2020; no shares issued and outstanding as of January 31, 2020 and April 30, 2020	0	0
Additional paid-in capital	998,271	988,141
Accumulated other comprehensive income	345	389
Accumulated deficit	(1,062,633)	(1,037,738)
Total stockholders' deficit	(63,988)	(49,180)
Total liabilities and stockholders' deficit	197,218	216,738
Class A Common Stock
Stockholders' deficit:
Common stock	3	3
Class B Common Stock
Stockholders' deficit:
Common stock	$ 26	$ 25

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (unaudited) (Parenthetical) - USD ($) $ in Thousands	Apr. 30, 2020	Jan. 31, 2020
Allowance for doubtful accounts receivable	$ 4,023	$ 2,164
Convertible preferred stock, par value (in usd per share)	$ 0.001	$ 0.001
Convertible preferred stock, shares authorized (shares)	0	0
Convertible preferred stock, shares issued (shares)	0	0
Convertible preferred stock, shares outstanding (shares)	0	0
Preferred stock par value (in usd per share) Share	$ 0.001	$ 0.001
Preferred stock authorized (shares)	10,000,000	10,000,000
Preferred stock issued (shares)	0	0
Preferred stock outstanding (shares)	0	0
Class A Common Stock
Common stock par value (usd per share)	$ 0.001	$ 0.001
Common stock authorized (shares)	3,263,659	3,263,659
Common stock issued (shares)	3,264,000	3,264,000
Common stock outstanding (shares)	3,264,000	3,264,000
Class B Common Stock
Common stock par value (usd per share)	$ 0.001	$ 0.001
Common stock authorized (shares)	500,000,000	500,000,000
Common stock issued (shares)	25,548,000	24,986,000
Common stock outstanding (shares)	25,548,000	24,986,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Apr. 30, 2020	Apr. 30, 2019
Revenues [Abstract]
Total revenue	$ 48,561	$ 40,798
Cost of Revenue [Abstract]
Total cost of revenue	14,109	12,804
Gross profit	34,452	27,994
Operating Expenses [Abstract]
Sales and marketing	29,096	35,949
Research and development	17,453	17,099
General and administrative	9,869	8,017
Total operating expenses	56,418	61,065
Loss from operations	(21,966)	(33,071)
Other expense, net	(2,724)	(2,325)
Loss before income taxes	(24,690)	(35,396)
Provision for income taxes	205	140
Net loss	$ (24,895)	$ (35,536)
Net loss per share, basic and diluted (in usd per share)	$ (0.88)	$ (1.32)
Weighted-average number of shares used in computing net loss per share, basic and diluted (shares)	28,450	26,966
Subscription
Revenues [Abstract]
Total revenue	$ 42,436	$ 34,391
Cost of Revenue [Abstract]
Total cost of revenue	9,105	8,035
Professional services and other
Revenues [Abstract]
Total revenue	6,125	6,407
Cost of Revenue [Abstract]
Total cost of revenue	$ 5,004	$ 4,769

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2020	Apr. 30, 2019
Statement of Comprehensive Income [Abstract]
Net loss	$ (24,895)	$ (35,536)
Foreign currency translation adjustments	(43)	(58)
Unrealized gains on securities available for sale	(1)	2
Comprehensive loss	$ (24,939)	$ (35,592)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity (Deficit) (unaudited) - USD ($) $ in Thousands	Total	Class A Common Stock	Class B Common Stock	Common StockClass A Common Stock	Common StockClass B Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income	Accumulated Deficit
Stockholders (deficit) equity, beginning balance (shares) at Jan. 31, 2019				3,263,659	23,434,542
Stockholders (deficit) equity, beginning balance at Jan. 31, 2019	$ 44,527			$ 3	$ 23	$ 956,145	$ 438	$ (912,082)
Increase (Decrease) in Stockholders' Equity (Deficit) [Roll Forward]
Vesting of restricted stock units (shares)					357,565
Vesting of restricted stock units	0
Shares repurchased for tax withholdings on vesting of restricted stock (shares)					(20,726)
Shares repurchased for tax withholdings on vesting of restricted stock	(900)					(900)
Issuance of common stock under employee stock purchase plan (shares)					253,104
Issuance of common stock under employee stock purchase plan	4,519				$ 1	4,518
Exercise of stock options (shares)					61,844
Exercise of stock options	1,338					1,338
Stock-based compensation expense	7,653					7,653
Exercise of common stock warrants (shares)					3,130
Exercise of common stock warrants	0
Other comprehensive loss	(56)						(56)
Net loss	(35,536)	$ (4,301)	$ (31,235)					(35,536)
Stockholders (deficit) equity, ending balance (shares) at Apr. 30, 2019				3,263,659	24,089,459
Stockholders (deficit) equity, ending balance at Apr. 30, 2019	21,545			$ 3	$ 24	968,754	382	(947,618)
Stockholders (deficit) equity, beginning balance (shares) at Jan. 31, 2020		3,264,000	24,986,000	3,263,659	24,985,698
Stockholders (deficit) equity, beginning balance at Jan. 31, 2020	(49,180)			$ 3	$ 25	988,141	389	(1,037,738)
Increase (Decrease) in Stockholders' Equity (Deficit) [Roll Forward]
Vesting of restricted stock units (shares)					99,762
Vesting of restricted stock units	0
Shares repurchased for tax withholdings on vesting of restricted stock (shares)					(4,578)
Shares repurchased for tax withholdings on vesting of restricted stock	(38)					(38)
Issuance of common stock under employee stock purchase plan (shares)					466,214
Issuance of common stock under employee stock purchase plan	$ 3,659				$ 1	3,658
Exercise of stock options (shares)	1,155				1,155
Exercise of stock options	$ 11					11
Stock-based compensation expense	6,499					6,499
Other comprehensive loss	(44)						(44)
Net loss	(24,895)	$ (2,856)	$ (22,039)					(24,895)
Stockholders (deficit) equity, ending balance (shares) at Apr. 30, 2020		3,264,000	25,548,000	3,263,659	25,548,251
Stockholders (deficit) equity, ending balance at Apr. 30, 2020	$ (63,988)			$ 3	$ 26	$ 998,271	$ 345	$ (1,062,633)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2020	Apr. 30, 2019
Cash flows from operating activities
Net loss	$ (24,895)	$ (35,536)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,293	1,764
Non-cash lease expense	951
Amortization of contract acquisition costs	3,408	2,678
Stock-based compensation expense	6,476	7,575
Other, net	879	(659)
Change in operating assets and liabilities:
Accounts receivable, net	18,323	12,214
Contract acquisition costs	(1,926)	(2,062)
Prepaid expenses and other	213	(4,493)
Accounts payable	45	551
Operating lease liabilities	(905)
Accrued expenses and other liabilities	(14,751)	(8,977)
Deferred revenue	(2,024)	267
Net cash used in operating activities	(12,913)	(26,678)
Cash flows from investing activities
Purchases of property and equipment	(1,363)	(1,474)
Purchases of securities available for sale	(11,149)	(63,008)
Proceeds from maturities of securities available for sale	16,600	0
Purchases of intangible assets	(104)	0
Net cash (used in) provided by investing activities	3,984	(64,482)
Cash flows from financing activities
Proceeds from shares issued in connection with employee stock purchase plan	3,659	4,518
Shares repurchased for tax withholdings on vesting of restricted stock	(38)	(900)
Proceeds from exercise of stock options	11	1,338
Net cash provided by financing activities	3,632	4,956
Effect of exchange rate changes on cash and cash equivalents	(3)	(6)
Net decrease in cash and cash equivalents	(5,300)	(86,210)
Cash and cash equivalents at beginning of period	80,843	176,973
Cash and cash equivalents at end of period	75,543	90,763
Supplemental disclosures of cash flow information
Cash paid for income taxes	245	0
Cash paid for interest	2,478	2,796
Non-cash investing and financing activities
Stock-based compensation capitalized as internal-use software	$ 116	$ 132

Overview and Basis of Presentat

Overview and Basis of Presentation	3 Months Ended
	Apr. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Overview and Basis of Presentation	Overview and Basis of Presentation Description of Business and Basis of Presentation Domo, Inc. (the Company) provides a cloud-based platform that digitally connects everyone from the CEO to the frontline employee with all the data, systems and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The Company is incorporated in Delaware. The Company's headquarters is located in American Fork, Utah and the Company has subsidiaries in the United Kingdom, Australia, Japan, Hong Kong, Singapore, New Zealand, and Canada. The accompanying unaudited condensed consolidated financial statements, which include the accounts of the Company and its wholly owned subsidiaries, have been prepared in conformity with accounting principles generally accepted in the United States of America or GAAP. All intercompany balances and transactions have been eliminated in consolidation. The Company’s fiscal year ends on January 31. Unaudited Condensed Consolidated Financial Statements The accompanying condensed consolidated balance sheet as of April 30, 2020, and the condensed consolidated statements of operations, comprehensive loss, stockholders' equity (deficit), and cash flows for the three months ended April 30, 2019 and 2020 are unaudited. The unaudited condensed consolidated financial statements have been prepared on a basis consistent with the annual consolidated financial statements and, in the opinion of management, reflect all adjustments necessary to state fairly the Company's financial position as of April 30, 2020 and its results of operations and cash flows for the three months ended April 30, 2019 and 2020. The financial data and the other financial information disclosed in the notes to these condensed consolidated financial statements related to the three-month periods are also unaudited. The results of operations for the three months ended April 30, 2020 are not necessarily indicative of the results to be expected for the fiscal year ending January 31, 2021 or for any other future year or interim period. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the related notes thereto as of and for the year ended January 31, 2020, included in the Company's Annual Report on Form 10-K. Use of Estimates The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. The Company bases its estimates on historical experience and on other assumptions that its management believes are reasonable under the circumstances. Actual results could differ from those estimates. The Company’s estimates and judgments include the determination of standalone selling prices for the Company’s services, which are used to determine revenue recognition for arrangements with multiple performance obligations; the amortization period for deferred contract acquisition costs; valuation of the Company’s stock-based compensation, including the underlying estimated fair value of common stock in periods prior to the date of the Company's IPO; useful lives of fixed assets; capitalization and estimated useful life of internal-use software; the incremental borrowing rate used to calculate the present value of capitalized leases; valuation estimates used when evaluating impairment of long-lived and intangible assets including goodwill; and the allowance for doubtful accounts. Foreign Currency The functional currencies of the Company’s foreign subsidiaries are the respective local currencies. The cumulative effect of translation adjustments arising from the use of differing exchange rates from period to period is included in accumulated other comprehensive income within the condensed consolidated balance sheets. Changes in the cumulative foreign translation adjustment are reported in the condensed consolidated statements of convertible preferred stock and stockholders’ equity (deficit) and the condensed consolidated statements of comprehensive loss. Transactions denominated in currencies other than the functional currency are remeasured at the end of the period and when the related receivable or payable is settled, which may result in transaction gains or losses. Foreign currency transaction gains and losses are included in other expense, net in the condensed consolidated statements of operations. All assets and liabilities denominated in a foreign currency are translated into U.S. dollars at the exchange rate on the balance sheet date. Revenue and expenses are translated at the average exchange rate during the period, and equity balances are translated using historical exchange rates. Segment Information The Company operates as one operating segment. The Company’s chief operating decision maker is its chief executive officer, who reviews financial information presented on a consolidated basis for purposes of making operating decisions, assessing financial performance and allocating resources.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Apr. 30, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Cash and Cash Equivalents Cash and cash equivalents consist of cash on hand, money market funds and highly liquid investments purchased with an original maturity date of 90 days or less from the date of purchase. The fair value of cash equivalents approximated their carrying value as of January 31, 2020 and April 30, 2020. Short-Term Investments The Company’s short-term investments are primarily comprised of commercial paper, U.S. treasury securities, asset-backed securities and corporate debt securities. The Company determines the appropriate classification of its short-term investments at the time of purchase and reevaluates such designation at each balance sheet date. The Company has classified and accounted for its short-term investments as available-for-sale securities as the Company may sell these securities at any time for use in its current operations or for other purposes, even prior to maturity. As a result, the Company classifies its short-term investments, including securities with stated maturities beyond twelve months, within current assets in the condensed consolidated balance sheets. The Company's short-term investments are recorded at fair value each reporting period. Unrealized gains and losses on these short-term investments are reported as a separate component of accumulated other comprehensive income in the condensed consolidated balance sheets until realized. Interest income is reported within other expense, net in the condensed consolidated statements of operations. The Company periodically evaluates its short-term investments to assess whether those with unrealized loss positions are other-than-temporarily impaired. The Company considers various factors in determining whether to recognize an impairment charge, including the length of time the investment has been in a loss position, the extent to which the fair value is less than the Company’s cost basis, and the financial condition and near-term prospects of the investee. If the Company determines that the decline in an investment’s fair value is other-than-temporary, the difference is recognized as an impairment loss in the condensed consolidated statements of operations. Realized gains and losses are reported in other expense, net in the condensed consolidated statements of operations. Accounts Receivable and Allowance for Doubtful Accounts Accounts receivable are recorded at the invoiced amount (net of allowances), do not require collateral, and do not bear interest. The Company’s payment terms generally provide that customers pay within 30 days of the invoice date. The Company maintains an allowance for doubtful accounts for amounts the Company does not expect to collect. In establishing the required allowance, management considers historical losses, current market conditions, customers’ financial condition, the age of the receivables, and current payment patterns. Account balances are written off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. Contract Acquisition Costs Contract acquisition costs, net are stated at cost net of accumulated amortization and primarily consist of deferred sales commissions, which are considered incremental and recoverable costs of obtaining a contract with a customer. Contract acquisition costs for initial contracts are deferred and then amortized on a straight-line basis over the period of benefit, which the Company has determined to be approximately four years. The period of benefit is determined by taking into consideration contractual terms, expected customer life, changes in the Company's technology and other factors. Contract acquisition costs for renewal contracts are not commensurate with contract acquisition costs for initial contracts and are recorded as expense when incurred if the period of benefit is one year or less. If the period of benefit is greater than one year, costs are deferred and then amortized on a straight-line basis over the period of benefit. Contract acquisition costs related to professional services and other performance obligations with a period of benefit of one year or less are recorded as expense when incurred. Amortization of contract acquisition costs is included in sales and marketing expenses in the accompanying condensed consolidated statements of operations. Amortization expense related to contract acquisition costs was $2.7 million and $3.4 million for the three months ended April 30, 2019 and 2020, respectively. There was no impairment charge in relation to contract acquisition costs for the periods presented. Property and Equipment Property and equipment, net, are stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets or over the related lease terms (if shorter). Repairs and maintenance costs are expensed as incurred. The estimated useful lives of property and equipment are as follows: Computer equipment and software 2-3 years Furniture, vehicles and office equipment 3 years Leasehold improvements Shorter of remaining lease term or estimated useful life Leases As a result of the adoption of ASC 842, the Company has made changes to its accounting policies with respect to leases. At the inception of a contract, the Company determines whether the contract is or contains a lease. Leases with a term greater than one year are recognized on the balance sheet as right-of-use (ROU) assets and lease liabilities. The Company has elected the short-term leases practical expedient which allows any leases with a term of 12 months or less to be considered short-term and thus will not have an ROU asset or lease liability recognized on the balance sheet. ROU assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As these leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate is the rate incurred to borrow on a collateralized basis over a similar term and amount equal to the lease payments in a similar economic environment. The operating lease ROU asset also includes any lease payments made in advance of lease expense and excludes lease incentives and initial direct costs incurred. Lease terms may include options to extend or terminate the lease, which the Company does not include in its minimum lease terms unless the options are reasonably certain to be exercised. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. ROU assets are subject to evaluation for impairment or disposal on a basis consistent with other long-lived assets. The Company has lease agreements with lease and non-lease components which the Company has elected to account for as a single lease component. On the lease commencement date, the Company establishes assets and liabilities for the present value of estimated future costs to retire long-lived assets at the termination or expiration of a lease. Such assets are depreciated over the lease term to operating expense. Income from subleases in recorded in other expense, net in the accompanying condensed consolidated statements of operations. Capitalized Internal-Use Software Costs The Company capitalizes certain costs related to development of its platform incurred during the application development stage. Costs related to preliminary project activities and post-implementation activities are expensed as incurred. Maintenance and training costs are also expensed as incurred. Capitalized costs are included in property and equipment. Capitalized internal-use software is amortized as subscription cost of revenue on a straight-line basis over its estimated useful life, which is generally three years. Management evaluates the useful lives of these assets on an annual basis and tests for impairment whenever events or changes in circumstances occur that could impact the recoverability of these assets. Goodwill and Intangible Assets Goodwill represents the excess of the purchase price in a business combination over the fair value of net tangible and intangible assets acquired. Goodwill and indefinite-lived intangible assets are not amortized, but rather tested for impairment at least annually on November 1 or more often if and when circumstances indicate that the carrying value may not be recoverable. Finite-lived intangible assets are amortized over their useful lives. Goodwill is tested for impairment based on reporting units. The Company periodically reevaluates the business and has determined that it continues to operate in one segment, which is also considered the sole reporting unit. Therefore, goodwill is tested for impairment at the consolidated level. The Company reviews its long-lived assets, including property and equipment, finite-lived intangible assets, and ROU assets for impairment whenever an event or change in facts and circumstances indicates that their carrying amounts may not be recoverable. Recoverability of these assets is measured by comparing the carrying amount to the estimated undiscounted future cash flows expected to be generated. If the carrying amount exceeds the undiscounted cash flows, the assets are determined to be impaired and an impairment charge is recognized as the amount by which the carrying amount exceeds fair value. There was no goodwill acquired and no impairment charges for goodwill or long-lived assets recorded during the periods presented. Revenue Recognition The Company derives revenue primarily from subscriptions to its cloud-based platform and professional services. Revenue is recognized when control of these services is transferred to customers in an amount that reflects the consideration to which the Company expects to be entitled to in exchange for those services, net of sales taxes. For sales through channel partners, the Company considers the channel partner to be the end customer for the purposes of revenue recognition as the Company's contractual relationships with channel partners do not depend on the sale of the Company's services to their customers and payment from the channel partner is not contingent on receiving payment from their customers. The Company's contractual relationships with channel partners do not allow returns, rebates, or price concessions. The price of subscriptions is generally fixed at contract inception and therefore, the Company's contracts do not contain a significant amount of variable consideration. Revenue recognition is determined through the following steps: • Identification of the contract, or contracts, with a customer • Identification of the performance obligations in the contract • Determination of the transaction price • Allocation of the transaction price to the performance obligations in the contract • Recognition of revenue when, or as, performance obligations are satisfied Subscription Revenue Subscription revenue primarily consists of fees paid by customers to access the Company’s cloud-based platform, including support services. The majority of the Company's subscription agreements have multi-year contractual terms and a smaller percentage have annual contractual terms. Revenue is recognized ratably over the related contractual term beginning on the date that the platform is made available to a customer. Access to the platform represents a series of distinct services as the Company continually provides access to and fulfills its obligation to the end customer over the subscription term. The series of distinct services represents a single performance obligation that is satisfied over time. The Company recognizes revenue ratably because the customer receives and consumes the benefits of the platform throughout the contract period. The Company's contracts are generally non-cancelable. Professional Services and Other Revenue Professional services revenue consists of implementation services sold with new subscriptions as well as professional services sold separately. Other revenue includes training and education. Professional services arrangements are billed in advance, and revenue from these arrangements is recognized as the services are provided, generally based on hours incurred. Training and education revenue is also recognized as the services are provided. Contracts with Multiple Performance Obligations Most of the Company's contracts with new customers contain multiple performance obligations, generally consisting of subscriptions and professional services. For these contracts, individual performance obligations are accounted for separately if they are distinct. The transaction price is allocated to the separate performance obligations on a relative standalone selling price basis. Standalone selling prices are determined based on historical standalone selling prices, taking into consideration overall pricing objectives, market conditions and other factors, including contract value, customer demographics and the number and types of users within the contract. Deferred Revenue The Company's contracts are typically billed annually in advance. Deferred revenue includes amounts collected or billed in excess of revenue recognized. Deferred revenue is recognized as revenue as the related performance obligations are satisfied. Deferred revenue that will be recognized during the succeeding twelve-month period is recorded as a current liability and the remaining portion is recorded as a noncurrent liability. Cost of Revenue Cost of subscription revenue consists primarily of third-party hosting services and data center capacity; employee-related costs directly associated with cloud infrastructure and customer support personnel, including salaries, benefits, bonuses and stock-based compensation; amortization expense associated with capitalized software development costs; depreciation expense associated with computer equipment and software; certain fees paid to various third parties for the use of their technology and services; and allocated overhead. Allocated overhead includes items such as information technology infrastructure, rent, and employee benefit costs. Cost of professional services and other revenue consists primarily of employee-related costs associated with these services, including stock-based compensation; third-party consultant fees; and allocated overhead. Advertising Costs Advertising costs are expensed as incurred. Advertising expense was $2.3 million and $2.1 million for the three months ended April 30, 2019 and 2020, respectively. Research and Development Research and development expenses consist primarily of employee-related costs for the design and development of the Company's platform, contractor costs to supplement staff levels, third-party web services, consulting services, and allocated overhead. Research and development expenses, other than software development costs qualifying for capitalization, are expensed as incurred. Stock-Based Compensation The Company has granted stock-based awards, consisting of stock options and restricted stock units, to its employees, certain consultants and certain members of its board of directors. The Company records stock-based compensation based on the grant date fair value of the awards, which include stock options and restricted stock units, and recognizes the fair value of those awards as expense using the straight-line method over the requisite service period of the award. For restricted stock units that contain performance conditions, the Company recognizes expense using the accelerated attribution method if it is probable the performance conditions will be met. The Company estimates the grant date fair value of stock options using the Black-Scholes option-pricing model. Stock-based compensation expense related to purchase rights issued under the 2018 Employee Stock Purchase Plan (ESPP) is based on the Black-Scholes option-pricing model fair value of the estimated number of awards as of the beginning of the offering period. Stock-based compensation expense is recognized using the straight-line method over the offering period. The determination of the grant date fair value of stock-based awards is affected by the estimated fair value of the Company's common stock as well as other assumptions and judgments, which are estimated as follows: • Fair Value Per Share of Common Stock . Because there was no public market for the Company's common stock prior to the IPO, the board of directors determined the common stock fair value at the grant date by considering numerous objective and subjective factors, including contemporaneous valuations of the Company’s common stock, actual operating and financial performance, market conditions, and performance of comparable publicly traded companies, business developments, the likelihood of achieving a liquidity event, and transactions involving preferred and common stock, among other factors. Subsequent to the IPO, the Company determines the fair value of common stock as of each grant date using the market closing price of the Company's Class B common stock on the date of grant. • Expected Term . The expected term is determined using the simplified method, which is calculated as the midpoint of the option’s contractual term and vesting period. The Company uses this method due to limited stock option exercise history. For the ESPP, the expected term is the beginning of the offering period to the end of each purchase period. • Expected Volatility . Since a public market for the Company's common stock did not exist prior to the IPO and, therefore, the Company does not have sufficient trading history of its common stock, expected volatility is estimated based on the weighted average of the volatility of similar publicly held companies and the Company's common stock over a period equivalent to the expected term of the awards. • Risk-free Interest Rate . The risk-free interest rate is determined using U.S. Treasury rates with a similar term as the expected term of the option. • Expected Dividend Yield . The Company has never declared or paid any cash dividends and does not presently plan to pay cash dividends in the foreseeable future. Consequently, the Company uses an expected dividend yield of zero. Income Taxes The Company accounts for income taxes in accordance with the liability method of accounting for income taxes. Under this method, the Company recognizes a liability or asset for the deferred income tax consequences of all temporary differences between the tax basis of assets and liabilities and their reported amounts in the condensed consolidated financial statements that will result in taxable or deductible amounts in future years when the reported amounts of the assets and liabilities are recovered or settled. These deferred income tax assets or liabilities are measured using the enacted tax rates that will be in effect when the differences are expected to affect taxable income. Valuation allowances are provided when it is more-likely-than-not that some or all of the deferred income tax assets may not be realized. In assessing the need for a valuation allowance, the Company has considered its historical levels of income, expectations of future taxable income and ongoing tax planning strategies. Because of the uncertainty of the realization of its deferred tax assets, the Company has a full valuation allowance for domestic net deferred tax assets, including net operating loss carryforwards, and tax credits related primarily to research and development. Realization of its deferred tax assets is dependent primarily upon future U.S. taxable income. Tax positions are recognized in the condensed consolidated financial statements when it is more-likely-than-not the position will be sustained upon examination by the tax authorities. The Company’s policy for recording interest and penalties related to income taxes, including uncertain tax positions, is to record such items as a component of the provision for income taxes. Concentrations of Risk and Significant Customers Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, short-term investments and accounts receivable. Cash denominated in currencies other than the United States dollar represented 9% and 13% of total cash, cash equivalents and short-term investments as of January 31, 2020 and April 30, 2020, respectively. The Company maintains its cash accounts with financial institutions where, at times, deposits exceed federal insured limits. The Company invests its excess cash in money market funds and in short-term investments consisting of highly-rated debt securities. No single customer accounted for more than 10% of revenue for the three months ended April 30, 2019 and 2020 or more than 10% of accounts receivable as of January 31, 2020 and April 30, 2020. The Company is primarily dependent upon third parties in order to meet the uptime and performance requirements of its customers. Any disruption of or interference with the Company's use of these third parties would impact operations. Net Loss per Share The Company computes net loss per share using the two-class method required for multiple classes of common stock and participating securities. The rights, including the liquidation and dividend rights, of the Class A common stock and Class B common stock are substantially identical, other than voting rights. Accordingly, the Class A common stock and Class B common stock share equally in the Company’s net losses. Before the IPO, the Company’s participating securities also included convertible preferred stock. The holders of convertible preferred stock did not have a contractual obligation to share in the Company’s losses, and as a result net losses were not allocated to these participating securities. Basic net loss per share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period increased by common shares that could be issued upon conversion or exercise of other outstanding securities to the extent those additional common shares would be dilutive. The dilutive effect of potentially dilutive securities is reflected in diluted net loss per share by application of the treasury stock method. During periods when the Company is in a net loss position, basic net loss per share is the same as diluted net loss per share as the effects of potentially dilutive securities are anti-dilutive. Recently Adopted Accounting Standards In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), which establishes a comprehensive new lease accounting model. Under the new guidance, at the commencement date, lessees are required to recognize a lease liability with a corresponding right-of-use asset. On February 1, 2020, the Company adopted Topic 842 using the modified retrospective approach with the effective date as of the date of initial application. Consequently, results for the three months ended April 30, 2020 are presented under Topic 842. Prior period amounts were not adjusted and continue to be reported in accordance with previous lease guidance under ASC Topic 840, Leases. The Company elected the package of practical expedients permitted under the transition guidance, which allows an entity to carryforward certain conclusions for leases that commenced prior to the effective date, including the determination of whether an existing contract contains a lease, the classification of the lease, and the accounting for initial direct costs. The Company performed evaluations of its contracts and determined each of its identified leases are operating leases. Upon adoption, the Company recognized cumulative operating lease liabilities of $12.8 million and operating right-of-use assets of $12.2 million. Recently Issued Accounting Pronouncements In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326), which requires the measurement and recognition of expected credit losses for certain financial instruments, which includes the Company's accounts receivable and available-for-sale debt securities. ASU 2016-13 replaces the existing incurred loss impairment model with an expected loss methodology, which will result in more timely recognition of credit losses. For available-for-sale debt securities, credit losses should be recorded through an allowance for credit losses. The Company expects to adopt this standard for the year ending January 31, 2021. The standard requires a cumulative effect adjustment to the balance sheet as of the beginning of the first reporting period in which the guidance is effective. The Company is evaluating the impact of the adoption of ASU 2016-13 on its consolidated financial statements.

Cash, Cash Equivalents and Shor

Cash, Cash Equivalents and Short-term Investments	3 Months Ended
	Apr. 30, 2020
Investments, Debt and Equity Securities [Abstract]
Cash, Cash Equivalents, and Short-term Investments	Cash, Cash Equivalents and Short-Term Investments The amortized cost, unrealized gain and estimated fair value of the Company’s cash equivalents and short-term investments as of January 31, 2020 and April 30, 2020 were as follows (in thousands): January 31, 2020 Amortized Cost Unrealized Gain Unrealized Loss Estimated Fair Value Cash $ 10,375 $ — $ — $ 10,375 Cash equivalents: Money market funds 45,654 — — 45,654 Certificates of deposit 15,021 — — 15,021 Reverse repurchase agreements 4,200 — — 4,200 Commercial paper 4,093 — — 4,093 Corporate debt securities 1,500 — — 1,500 Total cash and cash equivalents 80,843 — — 80,843 Short-term investments: Commercial paper 10,567 — — 10,567 U.S. treasury securities 4,999 1 — 5,000 Asset-backed securities 2,399 1 — 2,400 Total short-term investments 17,965 2 — 17,967 Total cash, cash equivalents and short-term investments $ 98,808 $ 2 $ — $ 98,810 April 30, 2020 Amortized Cost Unrealized Gain Unrealized Loss Estimated Fair Value Cash $ 14,385 $ — $ — $ 14,385 Cash equivalents: Money market funds 44,781 — — 44,781 Certificates of deposit 15,078 — — 15,078 Commercial paper 1,299 — — 1,299 Total cash and cash equivalents 75,543 — — 75,543 Short-term investments: Commercial paper 10,265 — — 10,265 Asset-backed securities 1,003 1 — 1,004 Corporate debt securities 1,302 — — 1,302 Total short-term investments 12,570 1 — 12,571 Total cash, cash equivalents and short-term investments $ 88,113 $ 1 $ — $ 88,114 All short-term investments were designated as available-for-sale securities and had contractual maturities due within less than one year as of January 31, 2020 and April 30, 2020. There were no material gross unrealized gains or losses from available-for-sale securities and no realized gains or losses from available-for-sale securities that were reclassified out of accumulated other comprehensive income for the three months ended April 30, 2020. For available-for-sale debt securities that have unrealized losses, the Company evaluates whether (1) it has the intention to sell any of these investments and (2) whether it is not more likely than not that it will be required to sell any of these available-for-sale debt securities before recovery of the entire amortized cost basis. Based on this evaluation, the Company determined that there were no other-than-temporary impairments associated with short-term investments as of April 30, 2020.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Apr. 30, 2020
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements Assets Measured at Fair Value on a Recurring Basis Financial instruments recorded at fair value in the financial statements are categorized as follows: • Level 1: Observable inputs that reflect quoted prices for identical assets or liabilities in active markets. • Level 2: Observable inputs, other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. • Level 3: Unobservable inputs reflecting management's assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available. The following table summarizes the assets measured at fair value on a recurring basis as of January 31, 2020 and April 30, 2020 by level within the fair value hierarchy (in thousands): January 31, 2020 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 45,654 $ — $ — $ 45,654 Certificates of deposit — 15,021 — 15,021 Reverse repurchase agreements — 4,200 4,200 Commercial paper — 4,093 4,093 Corporate debt securities — 1,500 — 1,500 Total cash equivalents 45,654 24,814 — 70,468 Short-term investments: Commercial paper — 10,567 — 10,567 U.S. treasury securities 5,000 — — 5,000 Asset-backed securities — 2,400 — 2,400 Total short-term investments 5,000 12,967 — 17,967 Total cash equivalents and short-term investments $ 50,654 $ 37,781 $ — $ 88,435 April 30, 2020 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 44,781 $ — $ — $ 44,781 Certificates of deposit — 15,078 — 15,078 Commercial paper — 1,299 1,299 Total cash equivalents 44,781 16,377 — 61,158 Short-term investments: Certificates of deposit — — — — Commercial paper — 10,265 10,265 Asset-backed securities — 1,004 — 1,004 Corporate debt securities — 1,302 — 1,302 Total short-term investments — 12,571 — 12,571 Total cash equivalents and short-term investments $ 44,781 $ 28,948 $ — $ 73,729 During the three months ended April 30, 2020, the Company had no transfers between levels of the fair value hierarchy of its assets and liabilities measured at fair value. Fair Value of Other Financial Instruments The carrying amounts of certain financial instruments, including cash held in banks, accounts receivable, accounts payable, accrued liabilities, and other liabilities approximate fair value due to their short-term maturities and are excluded from the fair value tables above.

Property and Equipment

Property and Equipment	3 Months Ended
	Apr. 30, 2020
Property, Plant and Equipment [Abstract]
Property and Equipment	Property and Equipment Property and equipment, net consisted of the following (in thousands): As of January 31, As of April 30, 2020 2020 Capitalized internal-use software development costs $ 24,305 $ 25,705 Computer equipment and software 4,714 4,747 Leasehold improvements 1,155 1,195 Furniture, vehicles and office equipment 836 836 31,010 32,483 Less accumulated depreciation and amortization (18,194) (19,372) $ 12,816 $ 13,111 Depreciation and amortization expense related to property and equipment was $1.6 million and $1.1 million for the three months ended April 30, 2019 and 2020, respectively. The Company capitalized $1.6 million and $1.4 million in software development costs during the three months ended April 30, 2019 and 2020, respectively. Amortization of capitalized software development costs was $0.8 million and $0.8 million for the three months ended April 30, 2019 and 2020, respectively.

Intangible Assets

Intangible Assets	3 Months Ended
	Apr. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Intangible Assets Intangible assets consisted of the following (in thousands): As of January 31, As of April 30, 2020 2020 Intellectual property excluding patents $ 2,354 $ 2,457 Software licenses 1,603 1,603 Patents 950 950 4,907 5,010 Less accumulated amortization (1,042) (1,195) $ 3,865 $ 3,815 Amortization expense related to intangible assets was $154,000 and $154,000 for the three months ended April 30, 2019 and 2020, respectively. Intellectual property excluding patents is considered an indefinite-lived asset due to the fact that it is renewable in perpetuity. Software licenses are amortized over an estimated useful life of three years. The patents were acquired and are being amortized over a weighted-average remaining useful life of approximately 7 years.

Accrued Expenses and Other Curr

Accrued Expenses and Other Current Liabilities	3 Months Ended
	Apr. 30, 2020
Payables and Accruals [Abstract]
Accrued Expenses and Other Current Liabilities	Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands): As of January 31, As of April 30, 2020 2020 Accrued payroll and benefits $ 7,802 $ 8,322 Accrued payroll taxes 9,915 7,446 Accrued expenses 8,068 7,153 Accrued bonus 9,847 2,740 Accrued commissions 4,041 2,117 Sales and other taxes payable 1,511 933 Employee stock purchase plan liability 3,016 785 Other accrued liabilities 2,273 1,396 $ 46,473 $ 30,892

Leases

Leases	3 Months Ended
	Apr. 30, 2020
Leases [Abstract]
Leases	Leases The Company leases office space under non-cancelable operating leases with various expiration dates through 2027. These leases require monthly lease payments that may be subject to annual increases throughout the lease term. Components of lease expense are summarized as follows (in thousands): Three Months Ended April 30, 2020 Operating lease expense $ 1,339 Short-term lease expense 739 Total lease expense $ 2,078 Lease term and discount rate information are summarized as follows: As of April 30, 2020 Weighted average remaining lease term (years) 4.7 Weighted average discount rate 10.0 % Maturities of lease liabilities as of April 30, 2020 are as follows (in thousands): Year Ending January 31: 2021 $ 3,401 2022 4,256 2023 1,664 2024 1,072 2025 1,104 Thereafter 3,414 Total lease payments 14,911 Less imputed interest (3,135) Present value of lease liabilities $ 11,776 The Company has various sublease agreements with third parties. These subleases have remaining lease terms of up to three years. Sublease income, which is recorded within other income, was $0.1 million during the three months ended April 30, 2020.

Deferred Revenue and Performanc

Deferred Revenue and Performance Obligations	3 Months Ended
	Apr. 30, 2020
Revenue from Contract with Customer [Abstract]
Deferred Revenue and Performance Obligations	Deferred Revenue and Performance Obligations Deferred Revenue Significant changes in the Company's deferred revenue balance for the three months ended April 30, 2020 were as follows (in thousands): Balance as of January 31, 2020 $ 109,744 Revenue recognized that was included in the deferred revenue balance at the beginning of the period: Subscription $ (37,297) Professional services and other (3,074) Total (40,371) Increase due to billings excluding amounts recognized as revenue during the period 38,347 Balance as of April 30, 2020 $ 107,720 Transaction Price Allocated to Remaining Performance Obligations Transaction price allocated to remaining performance obligations represents the remaining amount of revenue the Company expects to recognize from existing non-cancelable contracts, whether billed or unbilled. As of April 30, 2020, approximately $215.4 million of revenue was expected to be recognized from remaining performance obligations for subscription contracts. The Company expects to recognize approximately $114.3 million of this amount during the year ending January 31, 2021, with an additional $66.0 million being recognized during the year ending January 31, 2022, and the balance recognized thereafter. As of April 30, 2020, approximately $13.9 million of revenue was expected to be recognized from remaining performance obligations for professional services and other contracts, $10.5 million of which is expected to be recognized during the year ending January 31, 2021, and the balance recognized thereafter. Revenue by geographic area is determined by the billing address of the customer. The following table sets forth revenue by geographic area (in thousands): Three Months Ended April 30, 2019 2020 United States $ 30,246 $ 36,842 Japan 4,219 5,090 Other 6,333 6,629 Total $ 40,798 $ 48,561 Percentage of revenue by geographic area: United States 74 % 76 % Japan 10 % 10 % Other 16 % 14 % Other than the United States and Japan, no other individual country exceeded 10% of total revenue for the three months ended April 30, 2019 and 2020. As of April 30, 2020, substantially all of the Company’s property and equipment was located in the United States.

Geographic Information

Geographic Information	3 Months Ended
	Apr. 30, 2020
Revenue from Contract with Customer [Abstract]
Geographic Information	Deferred Revenue and Performance Obligations Deferred Revenue Significant changes in the Company's deferred revenue balance for the three months ended April 30, 2020 were as follows (in thousands): Balance as of January 31, 2020 $ 109,744 Revenue recognized that was included in the deferred revenue balance at the beginning of the period: Subscription $ (37,297) Professional services and other (3,074) Total (40,371) Increase due to billings excluding amounts recognized as revenue during the period 38,347 Balance as of April 30, 2020 $ 107,720 Transaction Price Allocated to Remaining Performance Obligations Transaction price allocated to remaining performance obligations represents the remaining amount of revenue the Company expects to recognize from existing non-cancelable contracts, whether billed or unbilled. As of April 30, 2020, approximately $215.4 million of revenue was expected to be recognized from remaining performance obligations for subscription contracts. The Company expects to recognize approximately $114.3 million of this amount during the year ending January 31, 2021, with an additional $66.0 million being recognized during the year ending January 31, 2022, and the balance recognized thereafter. As of April 30, 2020, approximately $13.9 million of revenue was expected to be recognized from remaining performance obligations for professional services and other contracts, $10.5 million of which is expected to be recognized during the year ending January 31, 2021, and the balance recognized thereafter. Revenue by geographic area is determined by the billing address of the customer. The following table sets forth revenue by geographic area (in thousands): Three Months Ended April 30, 2019 2020 United States $ 30,246 $ 36,842 Japan 4,219 5,090 Other 6,333 6,629 Total $ 40,798 $ 48,561 Percentage of revenue by geographic area: United States 74 % 76 % Japan 10 % 10 % Other 16 % 14 % Other than the United States and Japan, no other individual country exceeded 10% of total revenue for the three months ended April 30, 2019 and 2020. As of April 30, 2020, substantially all of the Company’s property and equipment was located in the United States.

Credit Facility

Credit Facility	3 Months Ended
	Apr. 30, 2020
Debt Disclosure [Abstract]
Credit Facility	Credit Facility In December 2017, the Company entered into an $80.0 million credit facility and drew $50.0 million at closing, which was scheduled to mature on January 1, 2021. In April 2018, the Company entered into an amendment to this credit facility pursuant to which the Company was able to incur an additional $20.0 million in term loan borrowings, for a total availability of $100.0 million under the amended facility. The Company drew the remaining $50.0 million during April 2018, which was scheduled to mature on May 1, 2021. The credit facility is secured by substantially all of the Company's assets. Under the amended credit facility, the Company was required to pay a $2.0 million fee upon the earlier of (1) the closing of a transaction in which the Company was acquired by a third party and (2) December 4, 2027. The obligation to pay this $2.0 million fee terminated upon the closing of the IPO. In January 2019, the Company entered into an amendment to this credit facility which extended the maturity date for both outstanding loans to October 1, 2022. The amendment also revised the maximum debt ratio financial covenant and increased the amount of the closing fee. Each term loan under the credit facility requires interest-only payments until the maturity date. A portion of the interest that accrues on the outstanding principal of each term loan is payable in cash on a monthly basis, which portion accrues at a floating rate equal to the greater of (1) 7% and (2) three-month LIBOR plus 5.5% per year. This interest rate was approximately 7.0% as of April 30, 2020. In addition, a portion of the interest that accrues on the outstanding principal of each term loan is capitalized and added to the principal amount of the outstanding term loan on a monthly basis, which portion accrues at a fixed rate equal to 2.5% per year. During the three months ended April 30, 2019 and 2020, $0.6 million and $0.7 million of interest was capitalized, respectively. The amended credit facility requires a closing fee of $7.0 million to be paid on the earliest of (1) the date the term loan is prepaid, (2) the term loan maturity date, which is October 1, 2022, and (3) the date the term loan becomes due and payable. Due to the long-term nature of the closing fee, it was recorded at present value as an increase to other liabilities, noncurrent and an increase to debt issuance costs. The closing fee liability will be accreted to its full value over the term of the loan, with such accretion recorded as interest expense in other expense, net in the condensed consolidated statements of operations. Debt issuance costs are presented as an offset to the outstanding principal balance of the term loans on the condensed consolidated balance sheets and are being amortized as interest expense in other expense, net in the condensed consolidated statements of operations over the term of the loan using the effective interest rate method. The balances in long-term debt consisted of the following: As of January 31, As of April 30, 2020 2020 Principal $ 105,123 $ 105,781 Less: unamortized debt issuance costs (4,049) (3,725) Net carrying amount $ 101,074 $ 102,056 The $100.0 million credit facility as amended contains customary conditions to borrowing, events of default and covenants, including covenants that restrict the Company's ability to dispose of assets, make material changes to the nature, control or location of the business, merge with or acquire other entities, incur indebtedness or encumbrances, make distributions to holders of the Company's capital stock, make certain investments or enter into transactions with affiliates. In addition, the Company is required to comply with a financial covenant based on the ratio of outstanding indebtedness to annualized recurring revenue. Under the amended facility, the maximum ratio is 0.75 on January 31, 2020 and April 30, 2020; 0.70 on July 31, 2020 and October 31, 2020; 0.65 on January 31, 2021 and April 30, 2021; and 0.60 on July 31, 2021 through the maturity date. The credit facility defines annualized recurring revenue as four times the Company's aggregate revenue for the immediately preceding quarter (net of recurring discounts and discounts for periods greater than one year) less the annual contract value of any customer contracts pursuant to which the Company was advised during such quarter would not be renewed at the end of the current term plus the annual contract value of existing customer contract increases during such quarter. This covenant is measured quarterly on a three The Company incurred interest expense of $3.1 million and $3.0 million for the three months ended April 30, 2019 and 2020, respectively. Stock Warrants In connection with the credit facility described above, in December 2017 the Company issued fully vested warrants to purchase 28,462 shares of Series D-2 convertible preferred stock (Series D-2 warrants) with an exercise price of $126.47 per share. The fair value of the Series D-2 warrants at the time of issuance was recorded as an increase to debt issuance costs. In connection with the April 2018 amendment, the Series D-2 warrants were amended to warrants to purchase 66,664 shares of Class B common stock with an exercise price of $45.00 per share (common warrants). Upon execution of the April 2018 amendment, unamortized debt issuance costs related to the Series D-2 warrants were adjusted based on the difference in fair value of the Series D-2 warrants and the common warrants at the time of the April 2018 amendment. In connection with the January 2019 amendment to the credit facility, the common warrants were amended to be exercisable for an aggregate of 125,000 shares of Class B common stock at an exercise price of $17.8736 per share (amended common warrants). Upon execution of the January 2019 amendment, unamortized debt issuance costs related to the common warrants were adjusted based on the difference in fair value of the common warrants and the amended common warrants at the time of the January 2019 amendment. See Note 12 for further details regarding stock warrants.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Apr. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Litigation Liabilities for loss contingencies arising from claims, assessments, litigation, fines, and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount can be reasonably estimated. Legal costs incurred in connection with loss contingencies are expensed as incurred. In October and November 2019, securities class action complaints were filed by certain stockholders of the Company against the Company, certain of the Company's current and former officers and directors, and the underwriters of the Company's June 2018 initial public offering alleging violations of securities laws and seeking unspecified damages. The Company believes these lawsuits are without merit and intends to defend the cases vigorously. The Company is unable to estimate a range of loss, if any, that could result were there to be an adverse final decision in these cases. If an unfavorable outcome were to occur in these cases, it is possible that the impact could be material to the Company's results of operations in the period(s) in which any such outcome becomes probable and estimable. The Company is involved in other legal proceedings from time to time arising in the normal course of business. Management believes that the outcome of these proceedings will not have a material impact on the Company's financial condition, results of operations, or liquidity. Warranties and Indemnification The Company’s subscription services are generally warranted to perform materially in accordance with the terms of the applicable customer service order under normal use and circumstances. Additionally, the Company’s arrangements generally include provisions for indemnifying customers against liabilities if its subscription services infringe a third party’s intellectual property rights. Furthermore, the Company may also incur liabilities if it breaches the security or confidentiality obligations in its arrangements. To date, the Company has not incurred significant costs and has not accrued a liability in the accompanying condensed consolidated financial statements as a result of these obligations. The Company has entered into service-level agreements with some of its customers defining levels of uptime reliability and performance and permitting those customers to receive credits for prepaid amounts related to unused subscription services if the Company fails to meet certain of the defined service levels. In very limited instances, the Company allows customers to early terminate their agreements if the Company repeatedly or significantly fails to meet those levels. If the Company repeatedly or significantly fails to meet contracted upon service levels, a contract may require a refund of prepaid unused subscription fees. To date, the Company has not experienced any significant failures to meet defined levels of uptime reliability and performance as set forth in its agreements and, as a result, the Company has not accrued any liabilities related to these agreements in the condensed consolidated financial statements. Other Purchase Commitments The Company has also entered into certain non-cancelable contractual commitments related to cloud infrastructure services in the ordinary course of business. There have been no material changes in these commitments as disclosed in the Annual Report on Form 10-K.

Stockholders' Equity (Deficit)

Stockholders' Equity (Deficit)	3 Months Ended
	Apr. 30, 2020
Equity [Abstract]
Stockholders' Equity (Deficit)	Stockholders' Equity (Deficit) Preferred Stock The Company's Board of Directors has the authority, without further action by the Company's stockholders, to issue up to 10,000,000 shares of preferred stock in one or more series and to fix the rights, preferences, and privileges thereof, including voting rights. As of January 31, 2020 and April 30, 2020, no shares of preferred stock were issued and outstanding. Common Stock The Company has two classes of common stock, Class A and Class B. Each share of Class A common stock is entitled to 40 votes per share and is convertible at any time into one share of Class B common stock. Each share of Class A common stock will convert automatically into one share of Class B common stock upon any transfer, whether or not for value. Each share of Class B common stock is entitled to one vote per share. Holders of Class A common stock and Class B common stock vote together as a single class on all matters (including the election of directors) submitted to a vote of stockholders, unless otherwise required by law or the Company's certificate of incorporation. Subject to preferences that may be applicable to any then-outstanding preferred stock, holders of Class A common stock and Class B common stock are entitled to receive dividends, if any, as may be declared by the Company's board of directors. At January 31, 2020 and April 30, 2020, there were 3,263,659 shares of Class A common stock authorized. There were 3,263,659 shares of Class A common stock issued and outstanding at January 31, 2020 and April 30, 2020. At January 31, 2020 and April 30, 2020, there were 500,000,000 shares of Class B common stock authorized and 24,985,698 and 25,548,251 shares of Class B common stock issued and outstanding, respectively. Class B Common Stock Warrants In connection with the amendment to the credit facility that occurred in April 2018, the warrants to purchase 28,462 shares of Series D-2 convertible preferred stock described in Note 10 were amended to warrants to purchase 66,664 shares of Class B common stock at an exercise price equal to $45.00 per share. The warrants are exercisable at any time prior to expiration, which was to occur on the earlier of the third anniversary of the IPO or December 2027. Due to the exercise price-related contingency that existed with the Class B common stock warrants, they were being accounted for as a liability and were included in other liabilities, noncurrent on the consolidated balance sheets. The liability was revalued each reporting period until the contingency was resolved and the change in fair value was recorded in other expense, net. The contingency was resolved on the effective date of the Company's IPO, at which time the liability was remeasured to fair value and the remaining liability balance was reclassified to additional paid-in capital within stockholders' equity. In connection with the January 2019 amendment to the credit facility, the warrants to purchase 66,664 shares of Class B common stock were amended to be exercisable for an aggregate of 125,000 shares of Class B common stock at an exercise price of $17.8736 per share. The warrants are exercisable at any time prior to expiration, which occurs on June 28, 2021 (the third anniversary of the IPO). The difference in the fair value of the Class B common stock warrants at the time of the amendment to the credit facility in January 2019 associated with the increase in shares and the lower exercise price was recorded as an adjustment to additional paid-in capital and debt issuance costs. In connection with a line of credit signed in July 2016, the Company issued a warrant to purchase 3,333 shares of Class B common stock with a strike price of $34.35 per share. The warrant expires ten years from the date of issuance. In connection with a loan signed in November 2011 and for which the last principal payment was made in September 2015, the Company issued a warrant to purchase 3,729 shares of Class B common stock with a strike price of $4.80 per share. The warrant expires ten years from the date of issuance. This warrant was net exercised in February 2019, resulting in the issuance of 3,130 shares of Class B common stock. In summary, as of April 30, 2020, there were 128,333 shares of Class B common stock subject to issuance under outstanding warrants, which are exercisable at prices ranging from $17.8736 to $34.35 per share.

Equity Incentive Plans

Equity Incentive Plans	3 Months Ended
	Apr. 30, 2020
Share-based Payment Arrangement [Abstract]
Equity Incentive Plans	Equity Incentive Plans In April 2011, Domo established the 2011 Equity Incentive Plan (2011 Plan), which was amended in September 2011 to provide for the issuance of stock options and other stock-based awards. In June 2018, the Company adopted the 2018 Equity Incentive Plan (2018 Plan). The 2018 Plan provides for the grant of incentive and nonstatutory stock options, restricted stock, RSUs, stock appreciation rights, performance units, and performance shares to employees, consultants, and members of the Company's board of directors. The number of shares available for issuance under the 2018 Plan includes an annual increase on the first day of each fiscal year equal to the least of: (1) 3,500,000 shares; (2) 5% of the outstanding shares of Class A and Class B common stock as of the last day of the immediately preceding fiscal year; and (3) such other amount as the Company's board of directors may determine no later than the last day of the immediately preceding year. During the three months ended April 30, 2020, the number of shares available for grant under the 2018 Plan was increased by 1,412,467 shares. As of April 30, 2020, there were 4,690,327 shares available for grant under the 2018 Plan. In connection with the IPO, the 2011 Plan was terminated. With the establishment of the 2018 Plan, the Company no longer grants equity-based awards under the 2011 Plan and any shares that expire, terminate, are forfeited or repurchased by the Company, or are withheld by the Company to cover tax withholding obligations, under the 2011 Plan, will become available for future grant under the 2018 Plan. The Company recognized stock-based compensation expense related to its equity incentive plans as follows (in thousands): Three Months Ended April 30, 2019 2020 Cost of revenue: Subscription $ 123 $ 226 Professional services and other 93 103 Sales and marketing 4,008 1,826 Research and development 2,065 1,877 General and administrative 1,238 2,397 Interest expense 48 47 Total $ 7,575 $ 6,476 Stock Options Stock options typically vest over a four The following table sets forth the outstanding common stock options and related activity for the three months ended April 30, 2020: Shares Weighted- Average Exercise Weighted-Average Remaining Contractual Term (years) Aggregate Intrinsic Value (in thousands) Outstanding as of January 31, 2020 1,745,415 $ 23.91 4.6 $ 5,152 Exercised (1,155) 9.43 Forfeited (1,291) 27.98 Expired (35,236) 28.51 Outstanding as of April 30, 2020 1,707,733 $ 23.82 4.4 $ 3,816 Vested and exercisable at April 30, 2020 1,664,907 $ 23.67 4.3 $ 3,816 The aggregate intrinsic value of options exercised was $1.0 million and $5,000 for the three months ended April 30, 2019 and 2020, respectively. The intrinsic value represents the excess of the estimated fair value of the Company's common stock on the date of exercise over the exercise price of each option. The intrinsic value of options as of April 30, 2020 is based on the market closing price of the Company's Class B common stock on that date. As of April 30, 2020, there was $0.5 million of unrecognized stock-based compensation expense related to outstanding stock options which is expected to be recognized over a weighted-average period of 1.3 years. Restricted Stock Units Restricted stock units (RSUs) granted under the Plan vest and settle upon the satisfaction of a service-based condition and, for RSUs granted prior to the IPO, a liquidity event-related performance vesting condition. The service-based condition for these awards is generally satisfied over three four one two two the liquidity event-related performance vesting condition associated with RSUs granted prior to the IPO was deemed probable of being satisfied. The following table sets forth the outstanding RSUs and related activity for the three months ended April 30, 2020: Number of Shares Weighted- Average Grant Date Fair Value Outstanding as of January 31, 2020 2,176,805 $ 23.40 Granted 1,982,350 19.01 Vested (111,239) 25.96 Canceled (196,834) 22.76 Outstanding as of April 30, 2020 3,851,082 $ 21.10 As of April 30, 2020, there was $65.0 million of unrecognized stock-based compensation expense related to outstanding RSUs which is expected to be recognized over a weighted-average period of 3.3 years. Employee Stock Purchase Plan In June 2018, the Company's board of directors adopted the ESPP. The number of shares of Class B common stock available for issuance under the ESPP increases on the first day of each fiscal year equal to the least of: (1) 1,050,000 shares of Class B common stock, (2) 1.5% of the outstanding shares of Class A and Class B common stock of the Company on the last day of the immediately preceding fiscal year, and (3) such other amount as the administrator of the ESPP may determine on or before the last day of the immediately preceding year. During the three months ended April 30, 2020, the number of shares available under the ESPP was increased by 423,740 shares. As of April 30, 2020, there were 899,405 shares available under the ESPP. The ESPP generally provides for consecutive overlapping 24-month offering periods comprised of four six nine Amounts deducted and accumulated by the participant will be used to purchase shares of Class B common stock at the end of each purchase period. The purchase price of the shares will be 85% of the lower of the fair market value of Class B common stock on the first trading day of each offering period or the fair market value of Class B common stock on the applicable exercise date. If the fair market value of a share of Class B common stock on the exercise date of an offering period is less than it was on the first trading day of that offering period, participants automatically will be withdrawn from that offering period following their purchase of shares on the exercise date and will be re-enrolled in a new 24-month offering period. Participants may end their participation at any time during an offering period and will be paid their accrued contributions that have not yet been used to purchase shares of Class B common stock. Participation ends automatically upon termination of employment. As of April 30, 2020, a total of 2,544,737 shares were issuable to employees based on contribution elections made under the ESPP. As of April 30, 2020, total unrecognized stock-based compensation related to the ESPP was $6.4 million, which is expected to be recognized over a weighted-average period of 1.5 years.

Income Taxes

Income Taxes	3 Months Ended
	Apr. 30, 2020
Income Tax Disclosure [Abstract]
Income Taxes	Income TaxesThe Company calculated the year-to-date income tax provision by applying the estimated annual effective tax rate to the year-to-date pre-tax income for each applicable jurisdiction and adjusted for discrete tax items in the period. The Company's income tax expense was $0.1 million and $0.2 million for the three months ended April 30, 2019 and 2020, respectively. The income tax expense for these periods was primarily attributable to foreign taxes.For the periods presented, the difference between the U.S. statutory rate and the Company's effective tax rate is primarily due to the full valuation allowance on its U.S. tax assets. The effective tax rate is also impacted by earnings realized in foreign jurisdictions

Net Loss Per Share

Net Loss Per Share	3 Months Ended
	Apr. 30, 2020
Earnings Per Share [Abstract]
Net Loss Per Share	Net Loss Per Share The Company computes net loss per share using the two-class method required for multiple classes of common stock and participating securities. The rights, including the liquidation and dividend rights, of the Class A common stock and Class B common stock are substantially identical, other than voting rights. Accordingly, the Class A common stock and Class B common stock share equally in the Company’s net losses. The following table sets forth the calculation of basic and diluted net loss per share during the periods presented (in thousands, except per share amounts): Three Months Ended April 30, 2019 2020 Class A Class B Class A Class B Numerator: Net loss $ (4,301) $ (31,235) $ (2,856) $ (22,039) Denominator: Weighted-average number of shares used in 3,264 23,702 3,264 25,186 Net loss per share, basic and diluted $ (1.32) $ (1.32) $ (0.88) $ (0.88) Since the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share for all periods as the inclusion of all potential common shares outstanding would have been anti-dilutive. The weighted-average impact of potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive was as follows (in thousands): Three Months Ended April 30, 2019 2020 Options to purchase common stock 610 183 Restricted stock units 1,409 477 Employee stock purchase program 264 239 Common stock warrants 62 — 2,346 899

Related Party Transactions

Related Party Transactions	3 Months Ended
	Apr. 30, 2020
Related Party Transactions [Abstract]
Related Party Transactions	Related Party TransactionsCertain members of the Company's board of directors serve as directors of and/or are executive officers of and, in some cases, are investors in, companies that are customers or vendors of the Company. Certain of the Company’s executive officers also serve as directors of or serve in an advisory capacity to companies that are customers or vendors of the Company. As of January 31, 2020 and April 30, 2020, the Company had $0.1 million and $0.1 million receivable from these customers, respectively. As of January 31, 2020 and April 30, 2020, amounts payable to these vendors were immaterial. During the three months ended April 30, 2019 and 2020, the Company recognized revenue of $0.3 million and $0.2 million, respectively, related to these customers. During the three months ended April 30, 2019 and 2020, the Company recognized expense of $0.1 million and $0.2 million, respectively, related to these vendors.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Apr. 30, 2020
Accounting Policies [Abstract]
Basis of Accounting	The accompanying unaudited condensed consolidated financial statements, which include the accounts of the Company and its wholly owned subsidiaries, have been prepared in conformity with accounting principles generally accepted in the United States of America or GAAP. All intercompany balances and transactions have been eliminated in consolidation. The Company’s fiscal year ends on January 31.
Use of Estimates	Use of Estimates The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. The Company bases its estimates on historical experience and on other assumptions that its management believes are reasonable under the circumstances. Actual results could differ from those estimates. The Company’s estimates and judgments include the determination of standalone selling prices for the Company’s services, which are used to determine revenue recognition for arrangements with multiple performance obligations; the amortization period for deferred contract acquisition costs; valuation of the Company’s stock-based compensation, including the underlying estimated fair value of common stock in periods prior to the date of the Company's IPO; useful lives of fixed assets; capitalization and estimated useful life of internal-use software; the incremental borrowing rate used to calculate the present value of capitalized leases; valuation estimates used when evaluating impairment of long-lived and intangible assets including goodwill; and the allowance for doubtful accounts.
Foreign Currency	Foreign Currency The functional currencies of the Company’s foreign subsidiaries are the respective local currencies. The cumulative effect of translation adjustments arising from the use of differing exchange rates from period to period is included in accumulated other comprehensive income within the condensed consolidated balance sheets. Changes in the cumulative foreign translation adjustment are reported in the condensed consolidated statements of convertible preferred stock and stockholders’ equity (deficit) and the condensed consolidated statements of comprehensive loss. Transactions denominated in currencies other than the functional currency are remeasured at the end of the period and when the related receivable or
Segment Information	Segment Information The Company operates as one operating segment. The Company’s chief operating decision maker is its chief executive officer, who reviews financial information presented on a consolidated basis for purposes of making operating decisions, assessing financial performance and allocating resources.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash and cash equivalents consist of cash on hand, money market funds and highly liquid investments purchased with an original maturity date of 90 days or less from the date of purchase. The fair value of cash equivalents approximated their carrying value as of January 31, 2020 and April 30, 2020.
Short-Term Investments	Short-Term Investments The Company’s short-term investments are primarily comprised of commercial paper, U.S. treasury securities, asset-backed securities and corporate debt securities. The Company determines the appropriate classification of its short-term investments at the time of purchase and reevaluates such designation at each balance sheet date. The Company has classified and accounted for its short-term investments as available-for-sale securities as the Company may sell these securities at any time for use in its current operations or for other purposes, even prior to maturity. As a result, the Company classifies its short-term investments, including securities with stated maturities beyond twelve months, within current assets in the condensed consolidated balance sheets.
Accounts Receivable	Accounts Receivable and Allowance for Doubtful AccountsAccounts receivable are recorded at the invoiced amount (net of allowances), do not require collateral, and do not bear interest. The Company’s payment terms generally provide that customers pay within 30 days of the invoice date.
Allowance for Doubtful Accounts	The Company maintains an allowance for doubtful accounts for amounts the Company does not expect to collect. In establishing the required allowance, management considers historical losses, current market conditions, customers’ financial condition, the age of the receivables, and current payment patterns. Account balances are written off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.
Contract Acquisition Costs and Revenue Recognition	Contract Acquisition Costs Contract acquisition costs, net are stated at cost net of accumulated amortization and primarily consist of deferred sales commissions, which are considered incremental and recoverable costs of obtaining a contract with a customer. Contract acquisition costs for initial contracts are deferred and then amortized on a straight-line basis over the period of benefit, which Revenue Recognition The Company derives revenue primarily from subscriptions to its cloud-based platform and professional services. Revenue is recognized when control of these services is transferred to customers in an amount that reflects the consideration to which the Company expects to be entitled to in exchange for those services, net of sales taxes. For sales through channel partners, the Company considers the channel partner to be the end customer for the purposes of revenue recognition as the Company's contractual relationships with channel partners do not depend on the sale of the Company's services to their customers and payment from the channel partner is not contingent on receiving payment from their customers. The Company's contractual relationships with channel partners do not allow returns, rebates, or price concessions. The price of subscriptions is generally fixed at contract inception and therefore, the Company's contracts do not contain a significant amount of variable consideration. Revenue recognition is determined through the following steps: • Identification of the contract, or contracts, with a customer • Identification of the performance obligations in the contract • Determination of the transaction price • Allocation of the transaction price to the performance obligations in the contract • Recognition of revenue when, or as, performance obligations are satisfied Subscription Revenue Subscription revenue primarily consists of fees paid by customers to access the Company’s cloud-based platform, including support services. The majority of the Company's subscription agreements have multi-year contractual terms and a smaller percentage have annual contractual terms. Revenue is recognized ratably over the related contractual term beginning on the date that the platform is made available to a customer. Access to the platform represents a series of distinct services as the Company continually provides access to and fulfills its obligation to the end customer over the subscription term. The series of distinct services represents a single performance obligation that is satisfied over time. The Company recognizes revenue ratably because the customer receives and consumes the benefits of the platform throughout the contract period. The Company's contracts are generally non-cancelable. Professional Services and Other Revenue Professional services revenue consists of implementation services sold with new subscriptions as well as professional services sold separately. Other revenue includes training and education. Professional services arrangements are billed in advance, and revenue from these arrangements is recognized as the services are provided, generally based on hours incurred. Training and education revenue is also recognized as the services are provided. Contracts with Multiple Performance Obligations Most of the Company's contracts with new customers contain multiple performance obligations, generally consisting of subscriptions and professional services. For these contracts, individual performance obligations are accounted for separately if they are distinct. The transaction price is allocated to the separate performance obligations on a relative standalone selling price basis. Standalone selling prices are determined based on historical standalone selling prices, taking into consideration overall pricing objectives, market conditions and other factors, including contract value, customer demographics and the number and types of users within the contract. Deferred Revenue The Company's contracts are typically billed annually in advance. Deferred revenue includes amounts collected or billed in excess of revenue recognized. Deferred revenue is recognized as revenue as the related performance obligations are satisfied. Deferred revenue that will be recognized during the succeeding twelve-month period is recorded as a current liability and the remaining portion is recorded as a noncurrent liability. Cost of Revenue Cost of subscription revenue consists primarily of third-party hosting services and data center capacity; employee-related costs directly associated with cloud infrastructure and customer support personnel, including salaries, benefits, bonuses and stock-based compensation; amortization expense associated with capitalized software development costs; depreciation expense associated with computer equipment and software; certain fees paid to various third parties for the use of their technology and services; and allocated overhead. Allocated overhead includes items such as information technology infrastructure, rent, and employee benefit costs.
Property and Equipment	Property and Equipment Property and equipment, net, are stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets or over the related lease terms (if shorter). Repairs and maintenance costs are expensed as incurred. The estimated useful lives of property and equipment are as follows: Computer equipment and software 2-3 years Furniture, vehicles and office equipment 3 years Leasehold improvements Shorter of remaining lease term or estimated useful life
Leases	Leases As a result of the adoption of ASC 842, the Company has made changes to its accounting policies with respect to leases. At the inception of a contract, the Company determines whether the contract is or contains a lease. Leases with a term greater than one year are recognized on the balance sheet as right-of-use (ROU) assets and lease liabilities. The Company has elected the short-term leases practical expedient which allows any leases with a term of 12 months or less to be considered short-term and thus will not have an ROU asset or lease liability recognized on the balance sheet. ROU assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As these leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. The incremental borrowing rate is the rate incurred to borrow on a collateralized basis over a similar term and amount equal to the lease payments in a similar economic environment. The operating lease ROU asset also includes any lease payments made in advance of lease expense and excludes lease incentives and initial direct costs incurred. Lease terms may include options to extend or terminate the lease, which the Company does not include in its minimum lease terms unless the options are reasonably certain to be exercised. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. ROU assets are subject to evaluation for impairment or disposal on a basis consistent with other long-lived assets. The Company has lease agreements with lease and non-lease components which the Company has elected to account for as a single lease component. On the lease commencement date, the Company establishes assets and liabilities for the present value of estimated future costs to retire long-lived assets at the termination or expiration of a lease. Such assets are depreciated over the lease term to operating expense. Income from subleases in recorded in other expense, net in the accompanying condensed consolidated statements of operations.
Capitalized Internal-Use Software Costs	Capitalized Internal-Use Software Costs The Company capitalizes certain costs related to development of its platform incurred during the application development stage. Costs related to preliminary project activities and post-implementation activities are expensed as incurred. Maintenance and training costs are also expensed as incurred. Capitalized costs are included in property and equipment.
Goodwill and Intangible Assets	Goodwill and Intangible Assets Goodwill represents the excess of the purchase price in a business combination over the fair value of net tangible and intangible assets acquired. Goodwill and indefinite-lived intangible assets are not amortized, but rather tested for impairment at least annually on November 1 or more often if and when circumstances indicate that the carrying value may not be recoverable. Finite-lived intangible assets are amortized over their useful lives. Goodwill is tested for impairment based on reporting units. The Company periodically reevaluates the business and has determined that it continues to operate in one segment, which is also considered the sole reporting unit. Therefore, goodwill is tested for impairment at the consolidated level. The Company reviews its long-lived assets, including property and equipment, finite-lived intangible assets, and ROU assets for impairment whenever an event or change in facts and circumstances indicates that their carrying amounts may not be recoverable. Recoverability of these assets is measured by comparing the carrying amount to the estimated undiscounted future cash flows expected to be generated. If the carrying amount exceeds the undiscounted cash flows, the assets are determined to be impaired and an impairment charge is recognized as the amount by which the carrying amount exceeds fair value. There was no goodwill acquired and no impairment charges for goodwill or long-lived assets recorded during the periods presented.
Advertising Costs	Advertising CostsAdvertising costs are expensed as incurred.
Research and Development	Research and Development Research and development expenses consist primarily of employee-related costs for the design and development of the Company's platform, contractor costs to supplement staff levels, third-party web services, consulting services, and allocated overhead. Research and development expenses, other than software development costs qualifying for capitalization, are expensed as incurred.
Stock-Based Compensation	Stock-Based Compensation The Company has granted stock-based awards, consisting of stock options and restricted stock units, to its employees, certain consultants and certain members of its board of directors. The Company records stock-based compensation based on the grant date fair value of the awards, which include stock options and restricted stock units, and recognizes the fair value of those awards as expense using the straight-line method over the requisite service period of the award. For restricted stock units that contain performance conditions, the Company recognizes expense using the accelerated attribution method if it is probable the performance conditions will be met. The Company estimates the grant date fair value of stock options using the Black-Scholes option-pricing model. Stock-based compensation expense related to purchase rights issued under the 2018 Employee Stock Purchase Plan (ESPP) is based on the Black-Scholes option-pricing model fair value of the estimated number of awards as of the beginning of the offering period. Stock-based compensation expense is recognized using the straight-line method over the offering period. The determination of the grant date fair value of stock-based awards is affected by the estimated fair value of the Company's common stock as well as other assumptions and judgments, which are estimated as follows: • Fair Value Per Share of Common Stock . Because there was no public market for the Company's common stock prior to the IPO, the board of directors determined the common stock fair value at the grant date by considering numerous objective and subjective factors, including contemporaneous valuations of the Company’s common stock, actual operating and financial performance, market conditions, and performance of comparable publicly traded companies, business developments, the likelihood of achieving a liquidity event, and transactions involving preferred and common stock, among other factors. Subsequent to the IPO, the Company determines the fair value of common stock as of each grant date using the market closing price of the Company's Class B common stock on the date of grant. • Expected Term . The expected term is determined using the simplified method, which is calculated as the midpoint of the option’s contractual term and vesting period. The Company uses this method due to limited stock option exercise history. For the ESPP, the expected term is the beginning of the offering period to the end of each purchase period. • Expected Volatility . Since a public market for the Company's common stock did not exist prior to the IPO and, therefore, the Company does not have sufficient trading history of its common stock, expected volatility is estimated based on the weighted average of the volatility of similar publicly held companies and the Company's common stock over a period equivalent to the expected term of the awards. • Risk-free Interest Rate . The risk-free interest rate is determined using U.S. Treasury rates with a similar term as the expected term of the option. • Expected Dividend Yield
Income Taxes	Income Taxes The Company accounts for income taxes in accordance with the liability method of accounting for income taxes. Under this method, the Company recognizes a liability or asset for the deferred income tax consequences of all temporary differences between the tax basis of assets and liabilities and their reported amounts in the condensed consolidated financial statements that will result in taxable or deductible amounts in future years when the reported amounts of the assets and liabilities are recovered or settled. These deferred income tax assets or liabilities are measured using the enacted tax rates that will be in effect when the differences are expected to affect taxable income. Valuation allowances are provided when it is more-likely-than-not that some or all of the deferred income tax assets may not be realized. In assessing the need for a valuation allowance, the Company has considered its historical levels of income, expectations of future taxable income and ongoing tax planning strategies. Because of the uncertainty of the realization of its deferred tax assets, the Company has a full valuation allowance for domestic net deferred tax assets, including net operating loss carryforwards, and tax credits related primarily to research and development. Realization of its deferred tax assets is dependent primarily upon future U.S. taxable income. Tax positions are recognized in the condensed consolidated financial statements when it is more-likely-than-not the position will be sustained upon examination by the tax authorities. The Company’s policy for recording interest and penalties related to income taxes, including uncertain tax positions, is to record such items as a component of the provision for income taxes.
Concentration of Risk	Concentrations of Risk and Significant Customers Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, short-term investments and accounts receivable. Cash denominated in currencies other than the United States dollar represented 9% and 13% of total cash, cash equivalents and short-term investments as of January 31, 2020 and April 30, 2020, respectively. The Company maintains its cash accounts with financial institutions where, at times, deposits exceed federal insured limits. The Company invests its excess cash in money market funds and in short-term investments consisting of highly-rated debt securities.
Concentration of Significant Customers	The Company is primarily dependent upon third parties in order to meet the uptime and performance requirements of its customers. Any disruption of or interference with the Company's use of these third parties would impact operations.
Net Loss Per Share	Net Loss per Share The Company computes net loss per share using the two-class method required for multiple classes of common stock and participating securities. The rights, including the liquidation and dividend rights, of the Class A common stock and Class B common stock are substantially identical, other than voting rights. Accordingly, the Class A common stock and Class B common stock share equally in the Company’s net losses. Before the IPO, the Company’s participating securities also included convertible preferred stock. The holders of convertible preferred stock did not have a contractual obligation to share in the Company’s losses, and as a result net losses were not allocated to these participating securities. Basic net loss per share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period increased by common shares that could be issued upon conversion or exercise of other outstanding securities to the extent those additional common shares would be dilutive. The dilutive effect of potentially dilutive securities is reflected in diluted net loss per share by application of the treasury stock method. During periods when the Company is in a net loss position, basic net loss per share is the same as diluted net loss per share as the effects of potentially dilutive securities are anti-dilutive.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Apr. 30, 2020
Accounting Policies [Abstract]
Schedule of Estimated Useful Lives of Property, Plant and Equipment	The estimated useful lives of property and equipment are as follows: Computer equipment and software 2-3 years Furniture, vehicles and office equipment 3 years Leasehold improvements Shorter of remaining lease term or estimated useful life Property and equipment, net consisted of the following (in thousands): As of January 31, As of April 30, 2020 2020 Capitalized internal-use software development costs $ 24,305 $ 25,705 Computer equipment and software 4,714 4,747 Leasehold improvements 1,155 1,195 Furniture, vehicles and office equipment 836 836 31,010 32,483 Less accumulated depreciation and amortization (18,194) (19,372) $ 12,816 $ 13,111

Cash, Cash Equivalents and Sh_2

Cash, Cash Equivalents and Short-term Investments (Tables)	3 Months Ended
	Apr. 30, 2020
Investments, Debt and Equity Securities [Abstract]
Cash, Cash Equivalents and Short-term Investments	The amortized cost, unrealized gain and estimated fair value of the Company’s cash equivalents and short-term investments as of January 31, 2020 and April 30, 2020 were as follows (in thousands): January 31, 2020 Amortized Cost Unrealized Gain Unrealized Loss Estimated Fair Value Cash $ 10,375 $ — $ — $ 10,375 Cash equivalents: Money market funds 45,654 — — 45,654 Certificates of deposit 15,021 — — 15,021 Reverse repurchase agreements 4,200 — — 4,200 Commercial paper 4,093 — — 4,093 Corporate debt securities 1,500 — — 1,500 Total cash and cash equivalents 80,843 — — 80,843 Short-term investments: Commercial paper 10,567 — — 10,567 U.S. treasury securities 4,999 1 — 5,000 Asset-backed securities 2,399 1 — 2,400 Total short-term investments 17,965 2 — 17,967 Total cash, cash equivalents and short-term investments $ 98,808 $ 2 $ — $ 98,810 April 30, 2020 Amortized Cost Unrealized Gain Unrealized Loss Estimated Fair Value Cash $ 14,385 $ — $ — $ 14,385 Cash equivalents: Money market funds 44,781 — — 44,781 Certificates of deposit 15,078 — — 15,078 Commercial paper 1,299 — — 1,299 Total cash and cash equivalents 75,543 — — 75,543 Short-term investments: Commercial paper 10,265 — — 10,265 Asset-backed securities 1,003 1 — 1,004 Corporate debt securities 1,302 — — 1,302 Total short-term investments 12,570 1 — 12,571 Total cash, cash equivalents and short-term investments $ 88,113 $ 1 $ — $ 88,114

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Apr. 30, 2020
Fair Value Disclosures [Abstract]
Summary of Assets Measured at Fair Value on Recurring Basis	The following table summarizes the assets measured at fair value on a recurring basis as of January 31, 2020 and April 30, 2020 by level within the fair value hierarchy (in thousands): January 31, 2020 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 45,654 $ — $ — $ 45,654 Certificates of deposit — 15,021 — 15,021 Reverse repurchase agreements — 4,200 4,200 Commercial paper — 4,093 4,093 Corporate debt securities — 1,500 — 1,500 Total cash equivalents 45,654 24,814 — 70,468 Short-term investments: Commercial paper — 10,567 — 10,567 U.S. treasury securities 5,000 — — 5,000 Asset-backed securities — 2,400 — 2,400 Total short-term investments 5,000 12,967 — 17,967 Total cash equivalents and short-term investments $ 50,654 $ 37,781 $ — $ 88,435 April 30, 2020 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 44,781 $ — $ — $ 44,781 Certificates of deposit — 15,078 — 15,078 Commercial paper — 1,299 1,299 Total cash equivalents 44,781 16,377 — 61,158 Short-term investments: Certificates of deposit — — — — Commercial paper — 10,265 10,265 Asset-backed securities — 1,004 — 1,004 Corporate debt securities — 1,302 — 1,302 Total short-term investments — 12,571 — 12,571 Total cash equivalents and short-term investments $ 44,781 $ 28,948 $ — $ 73,729

Property and Equipment (Tables)

Property and Equipment (Tables)	3 Months Ended
	Apr. 30, 2020
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	The estimated useful lives of property and equipment are as follows: Computer equipment and software 2-3 years Furniture, vehicles and office equipment 3 years Leasehold improvements Shorter of remaining lease term or estimated useful life Property and equipment, net consisted of the following (in thousands): As of January 31, As of April 30, 2020 2020 Capitalized internal-use software development costs $ 24,305 $ 25,705 Computer equipment and software 4,714 4,747 Leasehold improvements 1,155 1,195 Furniture, vehicles and office equipment 836 836 31,010 32,483 Less accumulated depreciation and amortization (18,194) (19,372) $ 12,816 $ 13,111

Intangible Assets (Tables)

Intangible Assets (Tables)	3 Months Ended
	Apr. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-lived Intangible Assets	Intangible assets consisted of the following (in thousands): As of January 31, As of April 30, 2020 2020 Intellectual property excluding patents $ 2,354 $ 2,457 Software licenses 1,603 1,603 Patents 950 950 4,907 5,010 Less accumulated amortization (1,042) (1,195) $ 3,865 $ 3,815
Schedule of Indefinite-Lived Intangible Assets	Intangible assets consisted of the following (in thousands): As of January 31, As of April 30, 2020 2020 Intellectual property excluding patents $ 2,354 $ 2,457 Software licenses 1,603 1,603 Patents 950 950 4,907 5,010 Less accumulated amortization (1,042) (1,195) $ 3,865 $ 3,815

Accrued Expenses and Other Cu_2

Accrued Expenses and Other Current Liabilities (Tables)	3 Months Ended
	Apr. 30, 2020
Payables and Accruals [Abstract]
Schedule of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consisted of the following (in thousands): As of January 31, As of April 30, 2020 2020 Accrued payroll and benefits $ 7,802 $ 8,322 Accrued payroll taxes 9,915 7,446 Accrued expenses 8,068 7,153 Accrued bonus 9,847 2,740 Accrued commissions 4,041 2,117 Sales and other taxes payable 1,511 933 Employee stock purchase plan liability 3,016 785 Other accrued liabilities 2,273 1,396 $ 46,473 $ 30,892

Leases (Tables)

Leases (Tables)	3 Months Ended
	Apr. 30, 2020
Leases [Abstract]
Components of Lease Expense	Components of lease expense are summarized as follows (in thousands): Three Months Ended April 30, 2020 Operating lease expense $ 1,339 Short-term lease expense 739 Total lease expense $ 2,078 Lease term and discount rate information are summarized as follows: As of April 30, 2020 Weighted average remaining lease term (years) 4.7 Weighted average discount rate 10.0 %
Maturities of Lease Liabilities	Maturities of lease liabilities as of April 30, 2020 are as follows (in thousands): Year Ending January 31: 2021 $ 3,401 2022 4,256 2023 1,664 2024 1,072 2025 1,104 Thereafter 3,414 Total lease payments 14,911 Less imputed interest (3,135) Present value of lease liabilities $ 11,776

Deferred Revenue and Performa_2

Deferred Revenue and Performance Obligations (Tables)	3 Months Ended
	Apr. 30, 2020
Revenue from Contract with Customer [Abstract]
Schedule of Changes in Deferred Revenue Balance	Significant changes in the Company's deferred revenue balance for the three months ended April 30, 2020 were as follows (in thousands): Balance as of January 31, 2020 $ 109,744 Revenue recognized that was included in the deferred revenue balance at the beginning of the period: Subscription $ (37,297) Professional services and other (3,074) Total (40,371) Increase due to billings excluding amounts recognized as revenue during the period 38,347 Balance as of April 30, 2020 $ 107,720

Geographic Information (Tables)

Geographic Information (Tables)	3 Months Ended
	Apr. 30, 2020
Revenue from Contract with Customer [Abstract]
Schedule of Revenue by Geographic Area	Revenue by geographic area is determined by the billing address of the customer. The following table sets forth revenue by geographic area (in thousands): Three Months Ended April 30, 2019 2020 United States $ 30,246 $ 36,842 Japan 4,219 5,090 Other 6,333 6,629 Total $ 40,798 $ 48,561 Percentage of revenue by geographic area: United States 74 % 76 % Japan 10 % 10 % Other 16 % 14 %

Credit Facility (Tables)

Credit Facility (Tables)	3 Months Ended
	Apr. 30, 2020
Debt Disclosure [Abstract]
Schedule of Debt	The balances in long-term debt consisted of the following: As of January 31, As of April 30, 2020 2020 Principal $ 105,123 $ 105,781 Less: unamortized debt issuance costs (4,049) (3,725) Net carrying amount $ 101,074 $ 102,056

Equity Incentive Plans (Tables)

Equity Incentive Plans (Tables)	3 Months Ended
	Apr. 30, 2020
Share-based Payment Arrangement [Abstract]
Schedule of Recognized Stock-based Compensation Expense	The Company recognized stock-based compensation expense related to its equity incentive plans as follows (in thousands): Three Months Ended April 30, 2019 2020 Cost of revenue: Subscription $ 123 $ 226 Professional services and other 93 103 Sales and marketing 4,008 1,826 Research and development 2,065 1,877 General and administrative 1,238 2,397 Interest expense 48 47 Total $ 7,575 $ 6,476
Schedule of Outstanding Stock Options and Related Activity	The following table sets forth the outstanding common stock options and related activity for the three months ended April 30, 2020: Shares Weighted- Average Exercise Weighted-Average Remaining Contractual Term (years) Aggregate Intrinsic Value (in thousands) Outstanding as of January 31, 2020 1,745,415 $ 23.91 4.6 $ 5,152 Exercised (1,155) 9.43 Forfeited (1,291) 27.98 Expired (35,236) 28.51 Outstanding as of April 30, 2020 1,707,733 $ 23.82 4.4 $ 3,816 Vested and exercisable at April 30, 2020 1,664,907 $ 23.67 4.3 $ 3,816
Schedule of Outstanding RSUs and Related Activity	The following table sets forth the outstanding RSUs and related activity for the three months ended April 30, 2020: Number of Shares Weighted- Average Grant Date Fair Value Outstanding as of January 31, 2020 2,176,805 $ 23.40 Granted 1,982,350 19.01 Vested (111,239) 25.96 Canceled (196,834) 22.76 Outstanding as of April 30, 2020 3,851,082 $ 21.10

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	3 Months Ended
	Apr. 30, 2020
Earnings Per Share [Abstract]
Schedule of Computation of Net Loss Per Share	The following table sets forth the calculation of basic and diluted net loss per share during the periods presented (in thousands, except per share amounts): Three Months Ended April 30, 2019 2020 Class A Class B Class A Class B Numerator: Net loss $ (4,301) $ (31,235) $ (2,856) $ (22,039) Denominator: Weighted-average number of shares used in 3,264 23,702 3,264 25,186 Net loss per share, basic and diluted $ (1.32) $ (1.32) $ (0.88) $ (0.88)
Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share	Since the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share for all periods as the inclusion of all potential common shares outstanding would have been anti-dilutive. The weighted-average impact of potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive was as follows (in thousands): Three Months Ended April 30, 2019 2020 Options to purchase common stock 610 183 Restricted stock units 1,409 477 Employee stock purchase program 264 239 Common stock warrants 62 — 2,346 899

Overview and Basis of Present_2

Overview and Basis of Presentation (Details)	3 Months Ended
	Apr. 30, 2020segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of operating segments	1

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Narrative (Details)	3 Months Ended
	Apr. 30, 2020USD ($)segment	Apr. 30, 2019USD ($)
Finite-Lived Intangible Assets [Line Items]
Amortization period for capitalized contract acquisition costs	4 years
Amortization of expense related to contract acquisition costs	$ 3,408,000	$ 2,678,000
Impairment charge in relation to contract acquisition costs	$ 0	0
Number of operating segments | segment	1
Goodwill acquired	$ 0	0
Impairment charges for goodwill or long-lived assets	0	0
Advertising expense	$ 2,100,000	$ 2,300,000
Capitalized internal-use software development costs
Finite-Lived Intangible Assets [Line Items]
Estimated useful lives of property and equipment	3 years

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Property and Equipment (Details)	3 Months Ended
	Apr. 30, 2020
Computer equipment and software | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives of property and equipment	2 years
Computer equipment and software | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful lives of property and equipment	3 years
Furniture, vehicles and office equipment
Property, Plant and Equipment [Line Items]
Estimated useful lives of property and equipment	3 years

Cash, Cash Equivalents and Sh_3

Cash, Cash Equivalents and Short-term Investments (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Apr. 30, 2020	Jan. 31, 2020
Cash equivalents:
Total cash and cash equivalents		$ 80,843
Cash and cash equivalents	$ 75,543	80,843
Short-term investments:
Amortized Cost	12,570	17,965
Unrealized Gain	1	2
Unrealized Loss	0	0
Estimated Fair Value	12,571	17,967
Total cash, cash equivalents and short-term investments
Amortized Cost	88,113	98,808
Unrealized Gain	1	2
Unrealized Loss	0	0
Estimated Fair Value	88,114	98,810
Commercial paper
Short-term investments:
Amortized Cost	10,265	10,567
Unrealized Gain	0	0
Unrealized Loss	0	0
Estimated Fair Value	10,265	10,567
U.S. treasury securities
Short-term investments:
Amortized Cost		4,999
Unrealized Gain		1
Unrealized Loss		0
Estimated Fair Value		5,000
Asset-backed securities
Short-term investments:
Amortized Cost	1,003	2,399
Unrealized Gain	1	1
Unrealized Loss	0	0
Estimated Fair Value	1,004	2,400
Corporate debt securities
Short-term investments:
Amortized Cost	1,302
Unrealized Gain	0
Unrealized Loss	0
Estimated Fair Value	1,302
Cash
Debt Securities, Available-for-sale [Line Items]
Cash	14,385	10,375
Money market funds
Cash equivalents:
Total cash and cash equivalents	44,781	45,654
Certificates of deposit
Cash equivalents:
Total cash and cash equivalents	15,078	15,021
Reverse repurchase agreements
Cash equivalents:
Total cash and cash equivalents		4,200
Commercial paper
Cash equivalents:
Total cash and cash equivalents	$ 1,299	4,093
Corporate debt securities
Cash equivalents:
Total cash and cash equivalents		$ 1,500

Fair Value Measurements - Asset

Fair Value Measurements - Assets Measured at Fair Value on Recurring Basis (Details) - USD ($) $ in Thousands	Apr. 30, 2020	Jan. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents		$ 80,843
Short-term investments	$ 12,571	17,967
Recurring Basis
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	61,158	70,468
Short-term investments	12,571	17,967
Total cash equivalents and short-term investments	73,729	88,435
Recurring Basis | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	44,781	45,654
Short-term investments	0	5,000
Total cash equivalents and short-term investments	44,781	50,654
Recurring Basis | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	16,377	24,814
Short-term investments	12,571	12,967
Total cash equivalents and short-term investments	28,948	37,781
Recurring Basis | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	0	0
Short-term investments	0	0
Total cash equivalents and short-term investments	0	0
Certificates of deposit | Recurring Basis
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0
Certificates of deposit | Recurring Basis | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0
Certificates of deposit | Recurring Basis | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0
Certificates of deposit | Recurring Basis | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0
Commercial paper | Recurring Basis
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	10,265	10,567
Commercial paper | Recurring Basis | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0	0
Commercial paper | Recurring Basis | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	10,265	10,567
Commercial paper | Recurring Basis | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments		0
U.S. treasury securities | Recurring Basis
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments		5,000
U.S. treasury securities | Recurring Basis | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments		5,000
U.S. treasury securities | Recurring Basis | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments		0
U.S. treasury securities | Recurring Basis | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments		0
Asset-backed securities | Recurring Basis
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	1,004	2,400
Asset-backed securities | Recurring Basis | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0	0
Asset-backed securities | Recurring Basis | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	1,004	2,400
Asset-backed securities | Recurring Basis | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0	0
Corporate debt securities | Recurring Basis
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	1,302
Corporate debt securities | Recurring Basis | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0
Corporate debt securities | Recurring Basis | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	1,302
Corporate debt securities | Recurring Basis | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Short-term investments	0
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	44,781	45,654
Money market funds | Recurring Basis
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	44,781	45,654
Money market funds | Recurring Basis | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	44,781	45,654
Money market funds | Recurring Basis | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	0	0
Money market funds | Recurring Basis | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	0	0
Certificates of deposit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	15,078	15,021
Certificates of deposit | Recurring Basis
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	15,078	15,021
Certificates of deposit | Recurring Basis | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	0	0
Certificates of deposit | Recurring Basis | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	15,078	15,021
Certificates of deposit | Recurring Basis | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	0	0
Reverse repurchase agreements
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents		4,200
Reverse repurchase agreements | Recurring Basis
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents		4,200
Reverse repurchase agreements | Recurring Basis | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents		0
Reverse repurchase agreements | Recurring Basis | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents		4,200
Reverse repurchase agreements | Recurring Basis | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents
Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	1,299	4,093
Commercial paper | Recurring Basis
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	1,299	4,093
Commercial paper | Recurring Basis | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	0	0
Commercial paper | Recurring Basis | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents	1,299	4,093
Commercial paper | Recurring Basis | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents
Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents		1,500
Corporate debt securities | Recurring Basis
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents		1,500
Corporate debt securities | Recurring Basis | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents		0
Corporate debt securities | Recurring Basis | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents		1,500
Corporate debt securities | Recurring Basis | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total cash equivalents		$ 0

Property and Equipment (Details

Property and Equipment (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2020	Apr. 30, 2019	Jan. 31, 2020
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 32,483		$ 31,010
Less accumulated depreciation and amortization	(19,372)		(18,194)
Property and equipment, net	13,111		12,816
Depreciation, excluding exchange rate effect	1,100	$ 1,600
Software development costs capitalized	1,400	1,600
Capitalized software development costs amortized	800	$ 800
Capitalized internal-use software development costs
Property, Plant and Equipment [Line Items]
Property and equipment, gross	25,705		24,305
Computer equipment and software
Property, Plant and Equipment [Line Items]
Property and equipment, gross	4,747		4,714
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,195		1,155
Furniture, vehicles and office equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 836		$ 836

Intangible Assets - Schedule of

Intangible Assets - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	Apr. 30, 2020	Jan. 31, 2020
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	$ 5,010	$ 4,907
Less accumulated amortization	(1,195)	(1,042)
Intangible assets, net	3,815	3,865
Patents
Finite-Lived Intangible Assets [Line Items]
Patents	950	950
Intellectual property excluding patents
Indefinite-lived Intangible Assets [Line Items]
Intellectual property excluding patents	2,457	2,354
Software licenses
Indefinite-lived Intangible Assets [Line Items]
Intellectual property excluding patents	$ 1,603	$ 1,603

Intangible Assets - Narrative (

Intangible Assets - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2020	Apr. 30, 2019
Finite-Lived Intangible Assets [Line Items]
Amortization of intangible assets	$ 154	$ 154
Patents
Finite-Lived Intangible Assets [Line Items]
Weighted-average amortization period	7 years

Accrued Expenses and Other Cu_3

Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Apr. 30, 2020	Jan. 31, 2020
Payables and Accruals [Abstract]
Accrued benefits	$ 8,322	$ 7,802
Accrued payroll taxes	7,446	9,915
Accrued expenses	7,153	8,068
Accrued commissions	2,117	4,041
Accrued bonus	2,740	9,847
Sales and other taxes payable	933	1,511
Employee stock purchase plan liability	785	3,016
Other accrued liabilities	1,396	2,273
Accrued expenses and other current liabilities	$ 30,892	$ 46,473

Leases - Components of Lease Ex

Leases - Components of Lease Expense (Details) $ in Thousands	3 Months Ended
	Apr. 30, 2020USD ($)
Leases [Abstract]
Operating lease expense	$ 1,339
Short-term lease expense	739
Total lease expense	$ 2,078
Weighted average remaining lease term (years)	4 years 8 months 12 days
Weighted average discount rate	10.00%

Leases - Maturities of Lease Li

Leases - Maturities of Lease Liabilities (Details) $ in Thousands	Apr. 30, 2020USD ($)
Leases [Abstract]
2021	$ 3,401
2022	4,256
2023	1,664
2024	1,072
2025	1,104
Thereafter	3,414
Total lease payments	14,911
Less imputed interest	(3,135)
Present value of lease liabilities	$ 11,776

Leases - Narrative (Details)

Leases - Narrative (Details) $ in Millions	3 Months Ended
	Apr. 30, 2020USD ($)
Leases [Abstract]
Subleases agreements, remaining lease terms	3 years
Sublease income	$ 0.1
Cash paid for operating lease liabilities	$ 1.1

Deferred Revenue and Performa_3

Deferred Revenue and Performance Obligations (Details) $ in Thousands	3 Months Ended
	Apr. 30, 2020USD ($)
Contract with Customer, Liability, Increase (Decrease) [Roll Forward]
Deferred revenue, beginning balance	$ 109,744
Revenue recognized that was included in the deferred revenue balance at the beginning of the period	(40,371)
Increase due to billings excluding amounts recognized as revenue during the period	38,347
Deferred revenue, ending balance	107,720
Subscription
Contract with Customer, Liability, Increase (Decrease) [Roll Forward]
Revenue recognized that was included in the deferred revenue balance at the beginning of the period	(37,297)
Professional services and other
Contract with Customer, Liability, Increase (Decrease) [Roll Forward]
Revenue recognized that was included in the deferred revenue balance at the beginning of the period	$ (3,074)

Deferred Revenue and Performa_4

Deferred Revenue and Performance Obligations - Narrative (Details) $ in Millions	Apr. 30, 2020USD ($)
Subscription
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue expected to be recognized from remaining performance obligations	$ 215.4
Subscription | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-05-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue expected to be recognized from remaining performance obligations	$ 114.3
Expected satisfaction period for remaining revenue performance obligations	9 months
Subscription | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-02-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue expected to be recognized from remaining performance obligations	$ 66
Expected satisfaction period for remaining revenue performance obligations	1 year
Professional services and other
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue expected to be recognized from remaining performance obligations	$ 13.9
Professional services and other | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-05-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue expected to be recognized from remaining performance obligations	$ 10.5
Expected satisfaction period for remaining revenue performance obligations	9 months

Geographic Information - Revenu

Geographic Information - Revenue by Geographic Area (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2020	Apr. 30, 2019
Concentration Risk [Line Items]
Total revenue	$ 48,561	$ 40,798
United States
Concentration Risk [Line Items]
Total revenue	$ 36,842	$ 30,246
United States | Revenue | Geographic concentration
Concentration Risk [Line Items]
Percentage of revenue by geographic area (percent)	76.00%	74.00%
Japan
Concentration Risk [Line Items]
Total revenue	$ 5,090	$ 4,219
Japan | Revenue | Geographic concentration
Concentration Risk [Line Items]
Percentage of revenue by geographic area (percent)	10.00%	10.00%
Other
Concentration Risk [Line Items]
Total revenue	$ 6,629	$ 6,333
Other | Revenue | Geographic concentration
Concentration Risk [Line Items]
Percentage of revenue by geographic area (percent)	14.00%	16.00%

Credit Facility - Narrative (De

Credit Facility - Narrative (Details) - USD ($)	1 Months Ended		3 Months Ended
	Apr. 30, 2018	Dec. 31, 2017	Apr. 30, 2020	Apr. 30, 2019	Jan. 31, 2019	Jul. 31, 2018
Line of Credit Facility [Line Items]
Interest expense incurred			$ 3,000,000	$ 3,100,000
Line of Credit | Credit Facility Maturing January 1, 2021
Line of Credit Facility [Line Items]
Borrowing capacity under credit facility	$ 100,000,000	$ 80,000,000
Draws made on line of credit	50,000,000	$ 50,000,000
Required closing fee under line of credit	2,000,000
Term loan | Credit Facility Maturing January 1, 2021
Line of Credit Facility [Line Items]
Borrowing capacity under credit facility	$ 20,000,000
Minimum interest rate of portion of outstanding principal accruing interest at floating rate (percent)			7.00%
Interest rate of portion of outstanding principal accruing interest at fixed rate (percent)			2.50%
LIBOR | Term loan | Credit Facility Maturing January 1, 2021
Line of Credit Facility [Line Items]
Spread on variable rate (percent)			5.50%
Secured credit facility | Line of Credit | Credit Facility Maturing January 1, 2021
Line of Credit Facility [Line Items]
Annualized recurring revenue as ratio of Company's aggregate revenue for preceding quarter			4
Covenant measurement period on a trailing basis			3 months
Secured credit facility | Term loan | Credit Facility Maturing January 1, 2021
Line of Credit Facility [Line Items]
Required closing fee under line of credit			$ 7,000,000
Interest rate at period end (percent)			7.00%
Interest capitalized			$ (700,000)	$ (600,000)
Total cash equivalents | Credit Facility Maturing January 1, 2021
Line of Credit Facility [Line Items]
Number of shares that can be purchased (shares)		28,462
Exercise price of warrants (in usd per share)		$ 126.47
Class B Common Stock Warrants
Line of Credit Facility [Line Items]
Number of shares that can be purchased (shares)			128,333
Class B Common Stock Warrants | Credit Facility Maturing January 1, 2021
Line of Credit Facility [Line Items]
Number of shares that can be purchased (shares)					125,000	66,664
Exercise price of warrants (in usd per share)						$ 45
January 31, 2020 and April 30, 2020 | Secured credit facility | Line of Credit | Credit Facility Maturing January 1, 2021
Line of Credit Facility [Line Items]
Maximum ratio			0.75
July 30, 2020 and October 31, 2020 | Secured credit facility | Line of Credit | Credit Facility Maturing January 1, 2021
Line of Credit Facility [Line Items]
Maximum ratio			0.70
January 31, 2021 | Secured credit facility | Line of Credit | Credit Facility Maturing January 1, 2021
Line of Credit Facility [Line Items]
Maximum ratio			0.65
July 31, 2021 through maturity date | Secured credit facility | Line of Credit | Credit Facility Maturing January 1, 2021
Line of Credit Facility [Line Items]
Maximum ratio			0.60

Credit Facility Schedule of Lon

Credit Facility Schedule of Long-Term Debt (Details) - USD ($) $ in Thousands	Apr. 30, 2020	Jan. 31, 2020
Debt Disclosure [Abstract]
Principal	$ 105,781	$ 105,123
Less: unamortized debt issuance costs	3,725	4,049
Net carrying amount	$ 102,056	$ 101,074

Stockholders' Equity - Narrativ

Stockholders' Equity - Narrative (Details) $ / shares in Units, $ in Thousands	3 Months Ended
	Apr. 30, 2019USD ($)shares	Apr. 30, 2020classvote$ / sharesshares	Jan. 31, 2020shares	Feb. 28, 2019shares	Jan. 31, 2019shares	Jul. 31, 2018$ / sharesshares	Dec. 31, 2017$ / sharesshares	Oct. 31, 2016shares	Nov. 30, 2011$ / sharesshares
Class of Stock [Line Items]
Preferred stock authorized (shares)		10,000,000	10,000,000
Preferred stock issued (shares)		0	0
Preferred stock outstanding (shares)		0	0
Number of classes of common stock | class		2
Exercise of common stock warrants | $	$ 0
Class A Common Stock
Class of Stock [Line Items]
Common Stock Voting Rights, Votes Entitled | vote		40
Shares to be issued upon conversion (shares)		1
Common stock authorized (shares)		3,263,659	3,263,659
Common stock issued (shares)		3,264,000	3,264,000
Stock outstanding (shares)		3,264,000	3,264,000
Class B Common Stock
Class of Stock [Line Items]
Common Stock Voting Rights, Votes Entitled | vote		1
Common stock authorized (shares)		500,000,000	500,000,000
Common stock issued (shares)		25,548,000	24,986,000
Stock outstanding (shares)		25,548,000	24,986,000
Class B Common Stock Warrants
Class of Stock [Line Items]
Number of shares that can be purchased (shares)		128,333
Credit Facility Maturing January 1, 2021 | Total cash equivalents
Class of Stock [Line Items]
Number of shares that can be purchased (shares)							28,462
Exercise price of warrants (in usd per share) | $ / shares							$ 126.47
Credit Facility Maturing January 1, 2021 | Class B Common Stock Warrants
Class of Stock [Line Items]
Number of shares that can be purchased (shares)					125,000	66,664
Exercise price of warrants (in usd per share) | $ / shares						$ 45
Credit Facility Maturing January 1, 2021 | Class B Common Stock Warrants | Minimum
Class of Stock [Line Items]
Exercise price of warrants (in usd per share) | $ / shares		$ 17.8736
Credit Facility Due July 18, 2018 | Class B Common Stock Warrants
Class of Stock [Line Items]
Number of shares that can be purchased (shares)								3,333
Warrants expiration period								10 years
Credit Facility Due July 18, 2018 | Class B Common Stock Warrants | Maximum
Class of Stock [Line Items]
Exercise price of warrants (in usd per share) | $ / shares		$ 34.35
November 2011 Loan | Class B Common Stock Warrants
Class of Stock [Line Items]
Number of shares that can be purchased (shares)				3,130					3,729
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | $ / shares									$ 4.80
Warrants expiration period									10 years
Common Stock | Class A Common Stock
Class of Stock [Line Items]
Common stock issued (shares)		3,263,659	3,263,659
Stock outstanding (shares)	3,263,659	3,263,659	3,263,659		3,263,659
Common Stock | Class B Common Stock
Class of Stock [Line Items]
Common stock issued (shares)		25,548,251	24,985,698
Stock outstanding (shares)	24,089,459	25,548,251	24,985,698		23,434,542

Equity Incentive Plans - Narrat

Equity Incentive Plans - Narrative (Details) $ / shares in Units, $ in Thousands	1 Months Ended		3 Months Ended
	Jun. 30, 2018shares	Apr. 30, 2011shares	Apr. 30, 2020USD ($)segmentshares	Apr. 30, 2019USD ($)$ / sharesshares	Jan. 31, 2020shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options exercised | $			$ 5	$ 1,000
Options to purchase common stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period			4 years
Term of award			ten
Weighted average grant-date fair value (in usd per share) | $ / shares				$ 14.95
Options granted in period (shares)			0	25,000
Compensation cost not yet recognized | $			$ 500
Recognition period for compensation cost not yet recognized			1 year 3 months 18 days
Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Recognition period for compensation cost not yet recognized			3 years 3 months 18 days
Compensation cost not yet recognized | $			$ 65,000
Class A Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock authorized (shares)			3,263,659		3,263,659
Common stock outstanding (shares)			3,264,000		3,264,000
Class B Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock authorized (shares)			500,000,000		500,000,000
Common stock outstanding (shares)			25,548,000		24,986,000
2018 Equity Incentive Plan (2018 Plan)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved for future issuance (shares)		3,500,000
Percentage of outstanding shares (percent)		5.00%
2018 Equity Incentive Plan (2018 Plan) | Class B Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved for future issuance (shares)			4,690,327
Additional shares authorized (shares)			1,412,467
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Duration of overlapping offering periods			24 months
Number of purchase periods in each offering period | segment			4
Duration of purchase periods			6 months
Duration of first purchase period in first offering period			9 months
Share purchase price as percentage of fair value of common stock (percent)			85.00%
Maximum annual contributions via payroll deductions (shares)			2,000
Percentage of eligible compensation (percent)			15.00%
Employee Stock Purchase Plan | ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of outstanding shares (percent)	1.50%
Number of shares available for grant (shares)			2,544,737
Recognition period for compensation cost not yet recognized			1 year 6 months
Compensation cost not yet recognized | $			$ 6,400
Employee Stock Purchase Plan | Class B Common Stock | ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved for future issuance (shares)	1,050,000		899,405
Additional shares authorized (shares)			423,740
Minimum | Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period			1 year
Service condition satisfaction period			3 years
Maximum | Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period			2 years
Service condition satisfaction period			4 years
Share-based Compensation Award, Tranche Two | Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period			2 years

Equity Incentive Plans - Recogn

Equity Incentive Plans - Recognized Stock-based Compensation Expense (Details) - 2011 Equity Incentive Plan (the Plan) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2020	Apr. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 6,476	$ 7,575
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	1,826	4,008
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	1,877	2,065
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	2,397	1,238
Interest expense
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	47	48
Subscription | Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	226	123
Professional services and other | Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 103	$ 93

Equity Incentive Plans - Outsta

Equity Incentive Plans - Outstanding Common Stock Options and Related Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Apr. 30, 2020	Apr. 30, 2019	Jan. 31, 2020
Shares Subject to Outstanding Options
Beginning balance of options outstanding (shares)	1,745,415
Exercised (shares)	(1,155)
Forfeited (shares)	(1,291)
Expired (shares)	(35,236)
Ending balance of options outstanding (shares)	1,707,733
Options vested and exercisable, outstanding (shares)	1,664,907
Weighted- Average Exercise Price per Share
Options outstanding, weighted average exercise price (in usd per share)	$ 23.91
Options exercised, weighted average exercise price (in usd per share)	9.43
Options forfeited, weighted average exercise price (in usd per share)	27.98
Options expired, weighted average exercise price (in usd per share)	28.51
Options outstanding, weighted average exercise price (in usd per share)	23.82
Options vested and exercisable, weighted average exercise price (in usd per share)	$ 23.67
Additional disclosures
Options outstanding, weighted average remaining contractual term	4 years 4 months 24 days	4 years 7 months 6 days
Options vested and exercisable, weighted average remaining contractual term	4 years 3 months 18 days
Options outstanding, aggregate intrinsic value	$ 3,816		$ 5,152
Options vested and exercisable, aggregate intrinsic value	$ 3,816

Equity Incentive Plans - Outs_2

Equity Incentive Plans - Outstanding RSUs and Related Activity (Details) - Restricted stock units	3 Months Ended
	Apr. 30, 2020$ / sharesshares
Number of Shares
Outstanding as of January 31, 2019 (shares) | shares	2,176,805
Granted (shares) | shares	1,982,350
Vested (shares) | shares	111,239
Canceled (shares) | shares	(196,834)
Outstanding as of April 30, 2019 (shares) | shares	3,851,082
Weighted- Average Grant Date Fair Value
Outstanding as of January 31,2019 (in usd per share) | $ / shares	$ 23.40
Granted (in usd per share) | $ / shares	19.01
Vested (in usd per share) | $ / shares	25.96
Canceled (in usd per share) | $ / shares	22.76
Outstanding as of April 30, 2019 (in usd per share) | $ / shares	$ 21.10

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2020	Apr. 30, 2019
Income Tax Disclosure [Abstract]
Income tax expense	$ 205	$ 140

Net Loss Per Share - Computatio

Net Loss Per Share - Computation of Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Apr. 30, 2020	Apr. 30, 2019
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Net loss	$ (24,895)	$ (35,536)
Weighted-average number of shares used in computing net loss per share, basic and diluted (shares)	28,450	26,966
Net loss per share, basic and diluted (in usd per share)	$ (0.88)	$ (1.32)
Class A Common Stock
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Net loss	$ (2,856)	$ (4,301)
Weighted-average number of shares used in computing net loss per share, basic and diluted (shares)	3,264	3,264
Net loss per share, basic and diluted (in usd per share)	$ (0.88)	$ (1.32)
Class B Common Stock
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Net loss	$ (22,039)	$ (31,235)
Weighted-average number of shares used in computing net loss per share, basic and diluted (shares)	25,186	23,702
Net loss per share, basic and diluted (in usd per share)	$ (0.88)	$ (1.32)

Net Loss Per Share - Antidiluti

Net Loss Per Share - Antidilutive Securities Excluded from Computation of Net Loss Per Share (Details) - shares shares in Thousands	3 Months Ended
	Apr. 30, 2020	Apr. 30, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities that were not included in the diluted net loss per share calculations (shares)	899	2,346
Options to purchase common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities that were not included in the diluted net loss per share calculations (shares)	183	610
Restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities that were not included in the diluted net loss per share calculations (shares)	477	1,409
Employee stock purchase program
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities that were not included in the diluted net loss per share calculations (shares)	239	264
Common stock warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities that were not included in the diluted net loss per share calculations (shares)	0	62

Related Party Transactions (Det

Related Party Transactions (Details) - Vendors of the company - USD ($) $ in Millions	3 Months Ended
	Apr. 30, 2020	Apr. 30, 2019	Jan. 31, 2020
Related Party Transaction [Line Items]
Due from related party	$ 0.1		$ 0.1
Revenue from related party	0.2	$ 0.3
Expenses recognized from transactions with related party	$ 0.2	$ 0.1